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Mendelian randomization (MR) is a method of exploiting genetic
variation to unbiasedly estimate a causal effect in presence of un-
measured confounding. MR is being widely used in epidemiology and
other related areas of population science. In this paper, we study sta-
tistical inference in the increasingly popular two-sample summary-
data MR design. We show a linear model for the observed associa-
tions approximately holds in a wide variety of settings when all the
genetic variants satisfy the exclusion restriction assumption, or in ge-
netic terms, when there is no pleiotropy. In this scenario, we derive a
maximum profile likelihood estimator with provable consistency and
asymptotic normality. However, through analyzing real datasets, we
find strong evidence of both systematic and idiosyncratic pleiotropy
in MR, echoing the omnigenic model of complex traits that is re-
cently proposed in genetics. We model the systematic pleiotropy by a
random effects model, where no genetic variant satisfies the exclusion
restriction condition exactly. In this case we propose a consistent and
asymptotically normal estimator by adjusting the profile score. We
then tackle the idiosyncratic pleiotropy by robustifying the adjusted
profile score. We demonstrate the robustness and efficiency of the
proposed methods using several simulated and real datasets.
1. Introduction. A common goal in epidemiology is to understand the
causal mechanisms of disease. If it was known that a risk factor causally
influenced an adverse health outcome, effort could be focused to develop
an intervention (e.g., a drug or public health intervention) to reduce the
risk factor and improve the population’s health. In settings where evidence
from a randomized controlled trial is lacking, inferences about causality are
made using observational data. The most common design of observational
study is to control for confounding variables between the exposure and the
outcome. However, this strategy can easily lead to biased estimates and
false conclusions when one or several important confounding variables are
MSC 2010 subject classifications: primary 65J05; secondary 46N60, 62F35
Keywords and phrases: causal inference, limited information maximum likelihood, weak
instruments, errors in variables, path analysis, pleiotropy effects
1
ar
X
iv
:1
80
1.
09
65
2v
3 
 [s
tat
.A
P]
  2
 Ja
n 2
01
9
2 Q. ZHAO ET AL.
overlooked.
Mendelian randomization (MR) is an alternative study design that lever-
ages genetic variation to produce an unbiased estimate of the causal effect
even when there is unmeasured confounding. MR is both old and new. It is a
special case of the instrumental variable (IV) methods [21], which date back
to the 1920s [54] and have a long and rich history in econometrics and statis-
tics. The first MR design was proposed by Katan [33] over 3 decades ago and
later popularized in genetic epidemiology by Davey Smith and Ebrahim [18].
As a public health study design, MR is rapidly gaining popularity from just
5 publications in 2003 to over 380 publications in the year 2016 [1]. However,
due to the inherent complexity of genetics (the understanding of which is
rapidly evolving) and the make-up of large international disease databases
being utilized in the analysis, MR has many unique challenges compared to
classical IV analyses in econometrics and health studies. Therefore, MR does
not merely involve plugging genetic instruments in existing IV methods. In
fact, the unique problem structure has sparked many recent methodological
advancements [7, 8, 23, 32, 34, 50, 51, 52].
Much of the latest developments in Mendelian randomization has been
propelled by the increasing availability and scale of genome-wide association
studies (GWAS) and other high-throughput genomic data. A particularly
attractive proposal is to automate the causal inference by using published
GWAS data [14], and a large database and software platform is currently
being developed [28]. Many existing IV and MR methods [e.g. 23, 40, 50],
though theoretically sound and robust to different kinds of biases, require
having individual-level data. Unfortunately, due to privacy concerns, the
access to individual-level genetic data is almost always restricted and usu-
ally only the GWAS summary statistics are publicly available. This data
structure has sparked a number of new statistical methods anchored within
the framework of meta-analysis [e.g. 7, 8, 26]. They are intuitively simple
and can be conveniently used with GWAS summary data, thus are quickly
gaining popularity in practice. However, the existing summary-data MR
methods often make unrealistic simplifying assumptions and generally lack
theoretical support such as statistical consistency and asymptotic sampling
distribution results.
This paper aims to resolve this shortcoming by developing statistical
methods that can be used with summary data, have good theoretical prop-
erties, and are robust to deviations of the usual IV assumptions. In the rest
of the Introduction, we will introduce a statistical model for GWAS sum-
mary data and demonstrate the MR problem using a real data example.
This example will be repeatedly used in subsequent sections to motivate
MENDELIAN RANDOMIZATION BY RAPS 3
and illustrate the statistical methods. We will conclude the Introduction by
discussing the methodological challenges in MR and outlining our solution.
1.1. Two-sample MR with summary data. We are interested in estimat-
ing the causal effect of an exposure variable X on an outcome variable Y .
The causal effect is confounded by unobserved variables, but we have p ge-
netic variants (single nucleotide polymorphisms, SNPs), Z1, Z2, . . . , Zp, that
are approximately valid instrumental variables (validity of an IV is defined
in Section 2.1). These IVs can help us to obtain unbiased estimate of the
causal effect even when there is unmeasured confounding. The precise prob-
lem considered in this paper is two-sample Mendelian randomization with
summary data, where we observe, for SNP j = 1, . . . , p, two associational
effects: the SNP-exposure effect γˆj and the SNP-outcome effect Γˆj . These
estimated effects are usually computed from two different samples using a
simple linear regression or logistic regression and are or are becoming avail-
able in public domain.
Throughout the paper we assume
Assumption 1. For every j ∈ {1, . . . , p} := [p], γˆj ∼ N(γj , σ2Xj), Γˆj ∼
N(Γj , σ
2
Y j), and the variances (σ
2
Xj , σ
2
Y j)j∈[p] are known. Furthermore, the
2p random variables (γˆj)j∈[p] and (Γˆj)j∈[p] are mutually independent.
The first assumption is quite reasonable as typically there are hundreds of
thousands of samples in modern GWAS, making the normal approximation
very accurate. We assume the variances of the GWAS marginal coefficients
are computed very accurately using the individual data (as they are typi-
cally based on tens of thousands of samples), but the methods developed
in this paper do not utilize individual data for statistical inference. The in-
dependence between (γˆj)j∈[p] and (Γˆj)j∈[p] is guaranteed because the effects
are computed from independent samples. The independence across SNPs is
reasonable if we only use uncorrelated SNPs by using a tool called linkage
disequilibrium (LD) clumping [28, 43, 44]. See Section 2 for more justifica-
tions of the last assumption.
Our key modeling assumption for summary-data MR is
Model for GWAS summary data. There exists a real number β0
such that
(1.1) Γj ≈ β0γj for almost all j ∈ [p].
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In Section 2 and Appendix A, we will explain why this model likely holds
for a variety of situations and why the parameter β0 may be interpreted as
the causal effect of X on Y . However, by investigating a real data example,
we will demonstrate in Section 3.5 that it is very likely that the strict equality
Γj = β0γj is not true for some if not most j. For now we will proceed with
the loose statement in (1.1), but it will be soon made precise in several ways.
Assumption 1 and model (1.1) suggest two different strategies of estimat-
ing β0:
1. Use the Wald ratio βˆj = Γˆj/γˆj [53] as each SNP’s individual estimate of
β0, then aggregate the estimates using a robust meta-analysis method.
Most existing methods for summary-data MR follow this line [7, 8, 26],
however the Wald estimator βˆj is heavily biased when γj is small, a
phenomenon known as “weak instrument bias”. See Bound, Jaeger and
Baker [6] and Section 1.3 below.
2. Treat equation (1.1) as an errors-in-variables regression problem [15],
where we are regressing Γˆj , whose expectation is Γj , on γˆj , which can
be regarded as a noisy observation of the actual regressor γj . Then we
directly estimate β0 in a robust way. This is the novel approach taken
in this paper and will be described and tested in detail.
1.2. A motivating example. Next we introduce a real data example that
will be repeatedly used in the development of this paper. In this example we
are interested in estimating the causal effect of a person’s Body Mass Index
(BMI) on Systolic Blood Pressure (SBP). We obtained publicly available
summary data from three GWAS with non-overlapping samples:
BMI-FEM: BMI in females by the Genetic Investigation of ANthropometric
Traits (GIANT) consortium [35] (sample size: 171977, unit: kg/m2).
BMI-MAL: BMI in males in the same study by the GIANT consortium (sam-
ple size: 152893, unit: kg/m2).
SBP-UKBB: SBP using the United Kingdom BioBank (UKBB) data (sample
size: 317754, unit: mmHg).
Using the BMI-FEM dataset and LD clumping, we selected 25 SNPs that are
genome-wide significant (p-value ≤ 5 × 10−8) and uncorrelated (10000 kilo
base pairs apart and R2 ≤ 0.001). We then obtained the 25 SNP-exposure
effects (γˆj)
25
j=1 and the corresponding standard errors from BMI-MAL and the
SNP-outcome effects (Γˆj)
25
j=1 and the corresponding standard errors from
SBP-UKBB. Later on in the paper we will consider an expanded set of 160
SNPs using the selection threshold p-value ≤ 10−4.
MENDELIAN RANDOMIZATION BY RAPS 5
−0.05
0.00
0.05
0.000 0.025 0.050 0.075
SNP effect on BMI
SN
P 
ef
fe
ct
 o
n 
SB
P
Method    Simple    Overdispersion + Robust loss
Fig 1: Scatter plot of Γˆj versus γˆj in the BMI-SBP example. Each point is
augmented by the standard error of Γˆj and γˆj on the vertical and horizontal
sides. For presentation purposes only, we chose the allele codings so that
all γˆj are positive. Solid lines are the regression slope fitted by two of our
methods. Dashed lines are the 95% confidence interval of the slopes. The
simple method using unadjusted profile score (PS, described in Section 3) has
smaller standard error than the more robust method using robust adjusted
profile score (RAPS, described in Section 5), because the simple method
does not consider genetic pleiotropy. See also Section 3.5.
Figure 1 shows the scatter plot of the 25 pairs of genetic effects. Since
they are measured with error, we added error bars of one standard error
to every point on both sides. The goal of summary-data MR is to find a
straight line through the origin that best fits these points. The statistical
method should also be robust to violations of model (1.1) since not all SNPs
satisfy the relation Γj = β0γj exactly. We will come back to this example in
Sections 3.5, 4.4 and 5.3 to illustrate our methods.
1.3. Statistical Challenges and organization of the paper. Compared to
classical IV analyses in econometrics and health studies, there are many
unique challenges in two-sample MR with summary data:
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1. Measurement error: Both the SNP-exposure and SNP-outcome effects
are clearly measured with error, but most of the existing methods
applicable to summary data assume that the sampling error of γˆj is
negligible so a weighted linear regression can be directly used [13].
2. Invalid instruments due to pleiotropy (the phenomenon that one SNP
can affect seemingly unrelated traits): A SNP Zj may causally affect
the outcome Y through other pathways not involving the exposure X.
In this case, the approximate linear model Γj ≈ β0γj might be entirely
wrong for some SNPs.
3. Weak instruments: Including a SNP j with very small γj can bias the
causal effect estimates (especially when the meta-analysis strategy is
used). It can also increase the variance of the estimator βˆ. See Sec-
tion 3.4.2.
4. Selection bias: To avoid the weak instrument bias, the standard prac-
tice in MR is to only use the genome-wide significant SNPs as instru-
ments (for example, as implemented in the TwoSampleMR R package
[28]). However, in many studies the same dataset is used for both se-
lecting SNPs and estimating γj , resulting in substantial selection bias
even if the selection threshold is very stringent.
Many previous works have considered one or some of these challenges.
Bowden et al. [9] proposed a modified Cochran’s Q statistic to detect the
heterogeneity due to pleiotropy instead of measurement error in γˆj . Address-
ing the issue of bias due to pleiotropy has attracted lots of attention in the
summary-data MR literature [7, 8, 26, 34, 51, 52], but no solid statistical
underpinning has yet been given. Other methods with more rigorous statis-
tical theory require individual-level data [23, 40, 50]. The weak instrument
problem has been thoroughly studied in the econometrics literature [e.g.
6, 25, 49], but all of this work operates in the individual-level data setting.
Finally, the selection bias has largely been overlooked in practice; common
wisdom has been that the selection biases the causal effects towards the null
(so it might be less serious) [27] and the bias is perhaps small when a strin-
gent selection criterion is used (in Section 7 we show this is not necessarily
the case).
In this paper we develop a novel approach to overcome all the aforemen-
tioned challenges by adjusting the profile likelihood of the summary data.
The measurement errors of γˆj and Γˆj (challenge 1) are naturally incorpo-
rated in computing the profile score. To tackle invalid IVs (challenge 2),
we will consider three models for the GWAS summary data with increasing
complexity:
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Model 1 (No pleiotropy). The linear model Γj = β0γj is true for every
j ∈ [p].
Model 2 (Systematic pleiotropy). Assume αj = Γj −β0γj i.i.d.∼ N(0, τ20 )
for j ∈ [p] and some small τ20 .
Model 3 (Systematic and idiosyncratic pleitropy). Assume αj , j ∈ [p]
are from a contaminated normal distribution: most αj are distributed as
N(0, τ20 ) but some |αj | may be much larger.
The consideration of these three models is motivated by not only the
theoretical models in Section 2 but also characteristics observed in real data
(Sections 3.5, 4.4 and 5.3) and recent empirical evidence in genetics [12, 46].
The three models are considered in Sections 3 to 5, respectively. We will
propose estimators that are provably consistent and asymptotically normal
in Models 1 and 2. We will then derive an estimator that is robust to a
small proportion of outliers in Model 3. We believe Model 3 best explains
the real data and the corresponding Robust Adjusted Profile Score (RAPS)
estimator is the clear winner in all the empirical examples.
Although weak IVs may bias the individual Wald’s ratio estimator (chal-
lenge 3), we will show, both theoretically and empirically, that including
additional weak IVs is usually helpful for our new estimators when there are
already strong IVs or many weak IVs. Finally, the selection bias (challenge
4) is handled by requiring use of an independent dataset for IV selection
as we have done in Section 1.2. This might not be possible in all practical
problems, but failing to use a separate dataset for IV selection can lead to
severe selection bias as illustrated by an empirical example in Section 7.
The rest of the paper is organized as follows. In Section 2 we give theo-
retical justifications of the model (1.1) for GWAS summary data. Then in
Sections 3 to 5 we describe an adjusted profile score approach of statistical
inference in Models 1 to 3, respectively. The paper is concluded with sim-
ulation examples in Section 6, another real data example in Section 7 and
more discussion in Section 8.
2. Statistical model for MR. In this Section we explain why the
approximate linear model (1.1) for GWAS summary data may hold in many
MR problems. We will put structural assumptions on the original data and
show that (1.1) holds in a variety of scenarios. Owing to this heuristic and
the wide availability of GWAS summary datasets, we will focus on statistical
inference for summary-data MR after Section 2.
8 Q. ZHAO ET AL.
2.1. Validity of instrumental variables. In order to study the origin of
the linear model (1.1) for summary data and give a causal interpretation to
the parameter β0, we must specify how the original data (X,Y, Z1, . . . , Zp)
are generated and how the summary statistics are computed. Consider the
following structural equation model [42] for the random variables:
X = g(Z1, . . . , Zp, U,EX), and
Y = f(X,Z1, . . . , Zp, U,EY ),
(2.1)
where U is the unmeasured confounder, EX and EY are independent ran-
dom noises, (EX , EY ) ⊥ (Z1, · · · , Zp, U) and EX ⊥ EY . In two-sample MR,
we observe nX i.i.d. realizations of (X,Z1, . . . , Zp) and independently nY
i.i.d. realizations of (Y,Z1, . . . , Zp). We shall also assume that the SNPs
Z1, Z2, . . . , Zp are discrete random variables supported on {0, 1, 2} and are
mutually independent. To ensure the independence, in practice we only in-
clude SNPs with low pairwise LD score in our model by using standard
genetics software like LD clumping [43].
A variable Zj is called a valid IV if it satisfies the following three criteria:
1. Relevance: Zj is associated with the exposure X. Notice that a SNP
that is correlated (in genetics terminology, in LD) with the actual
causal variant is also considered relevant and does not affect the sta-
tistical analysis below.
2. Effective random assignment: Zj is independent of the unmeasured
confounder U .
3. Exclusion restriction: Zj only affects the outcome Y through the ex-
posure X. In other words, the function f does not depend on Zj .
The causal model and the IV conditions are illustrated by a directed acyclic
graph (DAG) with a single instrument Z1 in Figure 2. Readers who are
unfamiliar with this language may find the tutorial by Baiocchi, Cheng and
Small [3] helpful.
In Mendelian randomization, the first criterion—relevance—is easily sat-
isfied by selecting SNPs that are significantly associated with X. Notice that
the genetic instrument does not need to be a causal SNP for the exposure.
The first criterion is considered satisfied if the SNP is correlated with the
actual causal SNP [29]. For example, in Figure 2, Z1 would be considered
“relevant” even if it is not causal for X but it is correlated with Z˜1. Aside
from the effects of population stratification, the second independence to un-
measured confounder assumption is usually easy to justify because most of
the common confounders in epidemiology are postnatal, which are indepen-
dent of genetic variants governed by Mendel’s Second Law of independent
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Fig 2: Causal DAG and the three criteria for valid IV. The proposed IV
Z1 can either be a causal variant for X or correlated with a causal variant
(Z˜1 in the figure). Z1 must be independent of any unmeasured confounder U
and cannot have any direct effect on Y or be correlated with another variant
that has direct effect on Y .
assortment [18, 20]. Empirically, there is generally a lack of confounding of
genetic variants with factors that confound exposures in conventional obser-
vational epidemiological studies [19].
The main concern for Mendelian randomization is the possible violation
of the third exclusion restriction criterion, due to a genetic phenomenon
called pleiotropy [18, 47], a.k.a. the multi-function of genes. The exclusion
restriction assumption does not hold if a SNP Zj affects the outcome Y
through multiple causal pathways and some do not involve the exposure
X. It is also violated if Zj is correlated with other variants (such as Z˜1 in
Figure 2) that affect Y through pathways that does not involveX. Pleiotropy
is widely prevalent for complex traits [48]. In fact, a “universal pleiotropy
hypothesis” developed by Fisher [22] and Wright [55] theorizes that every
genetic mutation is capable of affecting essentially all traits. Recent genetics
studies have found strong evidence that there is an extremely large number
of causal variants with tiny effect sizes on many complex traits, which in
part motivates our random effects Model 2.
Another important concept is the strength of an IV, defined as its asso-
ciation with the exposure X and usually measured by the F -statistic of an
instrument-exposure regression. Since we assume all the genetic instruments
are independent, the strength of SNP j can be assessed by comparing the
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statistic γˆ2j /σ
2
Xj with the quantiles of χ
2
1 (or equivalently F1,∞). When only a
few weak instruments are available (e.g. F -statistic less than 10), the usual
asymptotic inference is quite problematic [6]. In this paper, we primarily
consider the setting where there is at least one strong IV or many weak IVs.
2.2. Linear structural model. We are now ready to derive the linear
model (1.1) for GWAS summary data. Assuming all the IVs are valid, we
start with the linear structural model where functions f and g in (2.1) are
linear in their arguments (see also Bowden et al. [10]):
(2.2) X =
p∑
j=1
γjZj + ηXU + EX , Y = βX + ηY U + EY .
In this case, the GWAS summary statistics (γˆj)j∈[p] and (Γˆj)j∈[p] are usually
computed from simple linear regressions:
γˆj =
ĈovnX (X,Zj)
ĈovnX (Zj , Zj)
, Γˆj =
ĈovnY (Y,Zj)
ĈovnY (Zj , Zj)
.
Here Ĉovn is the sample covariance operator with n i.i.d. samples. Using
(2.2), it is easy to show that γˆj and Γˆj converge to normal distributions
centered at γj and Γj = βγj .
However, γˆj and γˆk are not exactly uncorrelated when j 6= k (same for Γˆj
and Γˆk), even if Zj and Zk are independent. After some simple algebra, one
can show that
Cor2(γˆj , γˆk) = 4 ·
γ2jVar(Zj)
Var(X)− γ2jVar(Zj)
γ2kVar(Zk)
Var(X)− γ2kVar(Zk)
.
Notice that γ2jVar(Zj)/Var(X) is the proportion of variance of X explained
by Zj . In the genetic context, a single SNP usually has very small predictabil-
ity of a complex trait [12, 31, 41, 46]. Therefore the correlation between γˆj
and γˆk (similarly Γˆj and Γˆk) is almost negligible. In conclusion, the linear
model (1.1) is approximately true when the phenotypes are believed to be
generated from a linear structural model.
To stick to the main statistical methodology, we postpone additional jus-
tifications of (1.1) in nonlinear structural models to Appendix A. In Ap-
pendix A.1, we will investigate the case where Y is binary and Γˆj is obtained
via logistic regression, as is very often the case in applied MR investigations.
In Appendix A.2, we will show the linearity between X and Z is also not
necessary.
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2.3. Violations of exclusion restriction. Equation (2.2) assumes that all
the instruments are valid. In reality, the exclusion restriction assumption is
likely violated for many if not most of the SNPs. To investigate its impact
in the model for summary data, we consider the following modification of
the linear structural model (2.2):
(2.3) X =
p∑
j=1
γjZj + ηXU + EX , Y = βX +
p∑
j=1
αjZj + ηY U + EY .
The difference between (2.2) and (2.3) is that the SNPs are now allowed to
directly affect Y and the effect size of SNP Zj is αj . In this case, it is not
difficult to see that the regression coefficient Γˆj estimates Γj = αj + γjβ.
This inspires our Models 2 and 3. In Model 2, we assume the direct effects αj
are normally distributed random effects. In Model 3, we further require the
statistical procedure to be robust against any extraordinarily large direct
effects αj . See Section 8 for more discussion on the assumptions on the
pleiotropy effects.
3. No pleiotropy: A profile likelihood approach. We now consider
Model 1, the case with no pleiotropy effects.
3.1. Derivation of the profile likelihood. A good place to start is writing
down the likelihood of GWAS summary data. Up to some additive constant,
the log-likelihood function is given by
(3.1) l(β, γ1, . . . , γp) = −1
2
[ p∑
j=1
(γˆj − γj)2
σ2Xj
+
p∑
j=1
(Γˆj − γjβ)2
σ2Y j
]
.
Since we are only interested in estimating β0, the other parameters, namely
γ := (γ1, · · · , γp), are considered nuisance parameters. There are two ways
to proceed from here. One is to view γ as incidental parameters [39] and try
to eliminate them from the likelihood. The other approach is to assume the
sequence γ1, γ2, · · · is generated from a fixed unknown distribution. When
p is large, it is possible to estimate the distribution of γ to improve the
efficiency using the second approach [38]. In this paper we aim to develop
a general method for summary-data MR that can be used regardless of the
number of SNPs being used, so we will take the first approach.
The profile log-likelihood of β is given by profiling out γ in (3.1):
(3.2) l(β) = max
γ
l(β,γ) = −1
2
p∑
j=1
(Γˆj − βγˆj)2
σ2Xjβ
2 + σ2Y j
.
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The maximum likelihood estimator of β is given by βˆ = arg maxβ l(β). It is
also called a Limited Information Maximum Likelihood (LIML) estimator
in the IV literature, a method due to Anderson and Rubin [2] with good
consistency and efficiency properties. See also Pacini and Windmeijer [40].
Equation (3.2) can be interpreted as a linear regression of Γˆ on γˆ, with the
intercept of the regression fixed to zero and the variance of each observation
equaling to σ2Xjβ
2 +σ2Y j . There is another meta-analysis interpretation. Let
βˆj = Γˆj/γˆj be the individual Wald’s ratio, then (3.2) can be rewritten as
(3.3) l(β) = −1
2
p∑
j=1
(βˆj − β)2
σ2Xjβ
2/γˆ2j + σ
2
Y j/γˆ
2
j
.
This expression is also derived by Bowden et al. [9] by defining a generalized
version of Cochran’s Q statistic to test for the presence of pleiotropy that
takes into account uncertainty in γˆj .
3.2. Consistency and asymptotic normality. It is well known that the
maximum likelihood estimator can be inconsistent when there are many
nuisance parameters in the problem [e.g. 39]. Nevertheless, due to the con-
nection with LIML, we expect and will prove below that βˆ is consistent and
asymptotically normal. However, we will also show that the profile likelihood
(3.2) can be information biased [37], meaning the profile likelihood ratio test
does not generally have a χ21 limiting distribution under the null.
A major distinction between our asymptotic setting and the classical
errors-in-variables regression setting is that our “predictors” γˆj , j ∈ [p] can
be individually weak. This can be seen, for example, from the linear struc-
tural model (2.2) that
(3.4) Var(X) =
p∑
j=1
γ2jVar(Zj) + η
2
XVar(U) + Var(EX).
Note that Zj takes on the value 0, 1, 2 with probability p
2
j , 2pj(1 − pj),
(1−pj)2 where pj is the allele frequency of SNP j. For simplicity, we assume
pj is bounded away from 0 and 1. In other words, only common genetic
variants are used as IVs. Together with (3.4), this implies that, if Var(X)
exists, ‖γ‖2 is bounded.
Assumption 2 (Collective IV strength is bounded). ‖γ‖22 = O(1).
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As a consequence, the average effect size is decreasing to 0,
1
p
p∑
j=1
|γj | ≤ ‖γ‖2/√p→ 0, when p→∞.
This is clearly different from the usual linear regression setting where the
“predictors” γˆj are viewed as random samples from a population. In the
one-sample IV literature, this many weak IV setting (p → ∞) has been
considered by Bekker [5], Stock and Yogo [49], Hansen, Hausman and Newey
[25] among many others in econometrics.
Another difference between our asymptotic setting and the errors-in-
variables regression is that our measurement errors also converge to 0 as
the sample size converges to infinity. Recall that nX is the sample size of
(X,Z1, . . . , Zp) and nY is the sample size of (Y,Z1, . . . , Zp). We assume
Assumption 3 (Variance of measurement error). Let n = min(nX , nY ).
There exist constants cσ, c
′
σ such that cσ/n ≤ σ2Xj ≤ c′σ/n and cσ/n ≤ σ2Y j ≤
c′σ/n for all j ∈ [p].
We write a = O(b) if there exists a constant c > 0 such that |a| ≤ cb, and
a = Θ(b) if there exists c > 0 such that c−1b ≤ |a| ≤ cb. In this notation,
Assumption 3 assumes the known variances σ2Xj and σ
2
Y j are Θ(1/n).
In the linear structural model (2.2), Var(γˆj) ≤ Var(X)/[Var(Zj)/nX ].
Thus Assumption 3 is satisfied when only common variants are used.
We are ready to state our first theoretical result.
Theorem 3.1. In Model 1 and under Assumptions 1 to 3, if p/(n2‖γ‖42)→
0, the maximum likelihood estimator βˆ is statistically consistent, i.e. βˆ
p→ β0.
A crucial quantity in Theorem 3.1 and the analysis below is the average
strength of the IVs, defined as
κ =
1
p
p∑
j=1
γ2j
σ2Xj
= Θ(n‖γ‖22/p).
An unbiased estimator of κ is the average F -statistic minus 1,
κˆ =
1
p
p∑
j=1
γˆ2j
σ2Xj
− 1.
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In practice, we require the average F -statistic to be large (say > 100) when
p is small, or not too small (say > 3) when p is large. Thus the condition
p/(n2‖γ‖42) = Θ
(
1/(pκ2)
) → 0 in Theorem 3.1 is usually quite reasonable.
In particular, since this condition only depends on the average instrument
strength κ, the estimator βˆ remains consistent even if a substantial propor-
tion of γj = 0 (for example, if the selection step in Section 1.2 using BMI-FEM
with less stringent p-value threshold finds many false positives).
Next we study the asymptotic normality of βˆ. Define the profile score to
be the derivative of the profile log-likelihood:
(3.5) ψ(β) := −l′(β) =
p∑
j=1
(Γˆj − βγˆj)(Γˆjσ2Xjβ + γˆjσ2Y j)
(σ2Xjβ
2 + σ2Y j)
2
.
The maximum likelihood estimator βˆ solves the estimating equation ψ(βˆ) =
0, and we consider the Taylor expansion around the truth β0:
(3.6) 0 = ψ(βˆ) = ψ(β0) + ψ
′(β0)(βˆ − β0) + 1
2
ψ′′(β˜)(βˆ − β0)2,
where β˜ is between βˆ and β0. Since βˆ is statistically consistent, the last
term on the right hand side of (3.6) can be proved to be negligible, and the
asymptotic normality of βˆ can be established by showing, for some appro-
priate V1 and V2, ψ(β0)
d→ N(0, V1) and ψ′(β0) p→ −V2. When V1 = V2, the
profile likelihood/score is called information unbiased [37].
Theorem 3.2. Under the assumptions in Theorem 3.1 and if at least one
of the following two conditions are true: (1) p → ∞ and ‖γ‖3/‖γ‖2 → 0;
(2) κ→∞; then we have
(3.7)
V2√
V1
(βˆ − β0) d→ N(0, 1),
where
V1 =
p∑
j=1
γ2j σ
2
Y j + Γ
2
jσ
2
Xj + σ
2
Xjσ
2
Y j
(σ2Xjβ
2
0 + σ
2
Y j)
2
, V2 =
p∑
j=1
γ2j σ
2
Y j + Γ
2
jσ
2
Xj
(σ2Xjβ
2
0 + σ
2
Y j)
2
.(3.8)
Notice that Theorem 3.2 is very general. It can be applied even in the
extreme situation p is fixed and κ → ∞ (a few strong IVs) or p → ∞ and
κ → 0 (many very weak IVs). The assumption ‖γ‖3/‖γ‖2 → 0 is used to
verify a Lyapunov’s condition for a central limit theorem. It essentially says
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the distribution of IV strengths is not too uneven and this assumption can
be further relaxed.
Using our rate assumption for the variances (Assumption 3), V2 = Θ(n‖γ‖22) =
Θ(pκ) and V1 = V2 + Θ(p). This suggests that the profile likelihood is infor-
mation unbiased if and only if κ→∞. In general, the amount of information
bias depends on the instrument strength κ. As an example, suppose β0 = 0
and σ2Y j ≡ σ2Y 1. Then by (3.7) and (3.8), Var(βˆ) ≈ V1/V 22 = (1 + κ−1)/V2.
Alternatively, if we make the simplifying assumption that σ2Y j/σ
2
Xj does not
depend on j, it is straightforward to show that
Var(βˆ) ∝ 1 + κ
−1
pκ
.
This approximation can be used as a rule of thumb to select the optimal
number of IVs.
In order to obtain standard error of βˆ, we must estimate V1 and V2 using
the GWAS summary data. We propose to replace γ2j and Γ
2
j in (3.8) by their
unbiased sample estimates, γˆ2j − σ2Xj and Γˆ2j − σ2Y j :
Vˆ1 =
p∑
j=1
(γˆ2j − σ2Xj)σ2Y j + (Γˆ2j − σ2Y j)σ2Xj + σ2Xjσ2Y j
(σ2Xj βˆ
2 + σ2Y j)
2
,
Vˆ2 =
p∑
j=1
(γˆ2j − σ2Xj)σ2Y j + (Γˆ2j − σ2Y j)σ2Xj
(σ2Xj βˆ
2 + σ2Y j)
2
.
Theorem 3.3. Under the same assumptions in Theorem 3.2, we have
Vˆ1 = V1(1 + op(1)), Vˆ2 = V2(1 + op(1)), and
(3.9)
Vˆ2√
Vˆ1
(βˆ − β0) d→ N(0, 1) as n→∞.
3.3. Weak IV bias. As mentioned in Section 1.3, many existing statistical
methods for summary-data MR ignore the measurement error in γˆj . We
briefly describe the amount of bias this may incur for the inverse variance
weighted (IVW) estimator [13]. The IVW estimator is equivalent to the
maximum likelihood estimator (3.2) assuming σ2Xj = 0, which has an explicit
expression and can be approximated by:
(3.10)
βˆIVW =
∑p
j=1 Γˆj γˆj∑p
j=1 γˆ
2
j
≈ E
[∑p
j=1 Γˆj γˆj
]
E
[∑p
j=1 γˆ
2
j
] = β‖γ‖2‖γ‖2 +∑pj=1 σ2Xj ≈ β1 + (1/κ) .
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Thus the amount of bias for the IVW estimator crucially depends on the
average IV strength κ. In comparison, our consistency result (Theorem 3.1)
only requires κ 1/√p.
3.4. Practical issues. Next we discuss several practical implications of
the theoretical results above.
3.4.1. Influence of a single IV. Under the assumptions in Theorem 3.2,
(3.6) and (3.5) lead to the following asymptotically linear form of βˆ:
βˆ =
1 + op(1)
V2
p∑
j=1
(Γˆj − β0γˆj)(Γˆjσ2Xjβ0 + γˆjσ2Y j)
(σ2Xjβ
2
0 + σ
2
Y j)
2
.
The above equation characterizes the influence of a single IV on the esti-
mator βˆ [24]. Intuitively, the IV Zj has large influence if it is strong or it
has large residual Γˆj − β0γˆj . Alternatively, we can measure the influence
of a single IV by computing the leave-one-out estimator βˆ−j that maxi-
mizes the profile likelihood with all the SNPs except Zj . In practice, it is
desirable to limit the influence of each SNP to make the estimator robust
against idiosyncratic pleiotropy (Model 3). This problem will be considered
in Section 5.
3.4.2. Selecting IVs. The formulas (3.7) and (3.8) suggest that using
extremely weak instruments may deteriorate the efficiency. Consider the fol-
lowing example in which we have a new instrument Zp+1 that is independent
of X, so γp+1 = 0. When adding Zp+1 to the analysis, V1 increases but V2
remains the same, thus the variance of βˆ becomes larger. Generally, this sug-
gests that we should screen out extremely weak IVs to improve efficiency. To
avoid selection bias, we recommend to use two independent GWAS datasets
in practice, one to screen out weak IVs and perform LD clumping and one
to estimate the SNP-exposure effects γj unbiasedly.
3.4.3. Residual quantile-quantile plot. One way to check the modeling
assumptions in Assumption 1 and Model 1 is the residual Quantile-Quantile
(Q-Q) plot, which plots the quantiles of standardized residuals
tˆj =
Γˆj − βˆγˆj√
βˆ2σ2Xj + σ
2
Y j
against the quantiles of the standard normal distribution. This is reasonable
because when βˆ = β0, tˆj ∼ N(0, 1) under Assumption 1 and Model 1. The
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Fig 3: Diagnostic plots of the Profile Score (PS) estimator. Left panel is a
Q-Q plot of the standardized residuals against standard normal. Right panel
is the leave-one-out estimates against instrument strength.
Q-Q plot is helpful at identifying IVs that do not satisfy the linear relation
Γj = β0γj , most likely due to genetic pleiotropy.
Besides the residual Q-Q plot, other diagnostic tools can be found in
related works. Bowden et al. [9] considered using each SNP’s contribution
to the generalized Q statistic to assess whether it is an outlier. Bowden et al.
[11] proposed a radial plot βˆj
√
wj versus
√
wj , where wj is the “weight” of
the j-th SNP in (3.3). Since these diagnostic methods are based on the Wald
ratio estimates βˆj , they can suffer from the weak instrument bias.
3.5. Example (continued). We conclude this Section by applying the pro-
file likelihood or Profile Score (PS) estimator in the BMI-SBP example
in Section 1.2. Here we used 160 SNPs that have p-values ≤ 10−4 in the
BMI-FEM dataset. The PS point estimate is 0.601 with standard error 0.054.
Figure 3 shows the Q-Q plot and the leave-one-out estimates discussed
in Section 3.4. The Q-Q plot clearly indicates the linear model Model 1
is not appropriate to describe the summary data. Although the standard-
ized residuals are roughly normally distributed, their standard deviations
are apparently larger than 1. This motivates the random pleiotropy effects
assumption in Model 2 which will be considered next.
4. Systematic pleiotropy: Adjusted profile score.
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4.1. Failure of the profile likelihood. Next we consider Model 2, where the
deviation from the linear relation Γj = β0γj is described by a random effects
model αj = Γj − β0γj ∼ N(0, τ20 ). The normality assumption is motivated
by Figure 3 and does not appear to be very consequential in the simulation
studies. In this model, the variance of Γˆ is essentially inflated by an unknown
additive constant τ20 :
γˆj ∼ N(γj , σ2Xj), Γˆj ∼ N(γjβ0, σ2Y j + τ20 ), j ∈ [p].
Similar to Section 3.1, the profile log-likelihood of (β, τ2) is given by
l(β, τ2) = −1
2
p∑
j=1
(Γˆj − βγˆj)2
σ2Xjβ
2 + σ2Y j + τ
2
+ log(σ2Y j + τ
2),
and the corresponding profile score equations are
∂
∂β
l(β, τ2) = 0,
∂
∂τ2
l(β, τ2) = 0.
It is straightforward to verify that the first estimating equation is unbiased,
i.e. it has expectation 0 at (β0, τ
2
0 ). However, the other profile score is
(4.1)
∂
∂τ2
l(β, τ2) =
1
2
p∑
j=1
(Γˆj − βγˆj)2
(σ2Xjβ
2 + σ2Y j + τ
2)2
− 1
σ2Y j + τ
2
.
It is easy to see that its expectation is not equal to 0 at the true value
(β, τ2) = (β0, τ
2
0 ). This means the profile score is biased in Model 2, thus the
corresponding maximum likelihood estimator is not statistically consistent.
4.2. Adjusted profile score. The failure of maximizing the profile like-
lihood should not be surprising, because it is well known that maximum
likelihood estimator can be biased when there are many nuisance param-
eters [39]. There are many proposals to modify the profile likelihood, see,
for example, Barndorff-Nielsen [4], Cox and Reid [17]. Here we take the ap-
proach of McCullagh and Tibshirani [37] that directly modifies the profile
score so it has mean 0 at the true value. The Adjusted Profile Score (APS)
is given by ψ(β, τ2) = (ψ1(β, τ
2), ψ2(β, τ
2)), where
ψ1(β, τ
2) = − ∂
∂β
l(β, τ2) =
p∑
j=1
(Γˆj − βγˆj)(Γˆjσ2Xjβ + γˆj(σ2Y j + τ2))
(σ2Xjβ
2 + σ2Y j + τ
2)2
,(4.2)
ψ2(β, τ
2) =
p∑
j=1
σ2Xj
(Γˆj − βγˆj)2 − (σ2Xjβ2 + σ2Y j + τ2)
(σ2Xjβ
2 + σ2Y j + τ
2)2
.(4.3)
MENDELIAN RANDOMIZATION BY RAPS 19
Compared to (4.1), we replaced (σ2Y j + τ
2)−1 by (σ2Xjβ
2 + σ2Y j + τ
2)−1, so
each summand in (4.3) has mean 0 at (β0, τ
2
0 ). We also weighted the IVs by
σ2Xj in (4.3), which is useful in the proof of statistical consistency.
Notice that both the denominators and numerators in ψ1 and ψ2 are poly-
nomials of β and τ2. However, the denominators are of higher degrees. This
implies that the APS estimating equations always have diverging solutions:
ψ(β, τ2) → 0 if β → ±∞ or τ2 → ∞. We define the APS estimator (βˆ, τˆ2)
to be the non-trivial finite solution to ψ(β, τ2) = 0 if it exists.
4.3. Consistency and asymptotic normality. Because of the diverging so-
lutions of the APS equations, we need to impose some compactness con-
straints on the parameter space to study the asymptotic property of (βˆ, τˆ2):
Assumption 4. (β0, pτ
2
0 ) is in the interior of a bounded set B ⊂ R×R+.
The overdispersion parameter τ20 is scaled up in Assumption 4 by p. This
is motivated by the linear structural model (2.3), where
∑2
j=1 τ
2
0 Var(Zj) =
Θ(pτ20 ) is the variance of Y explained by the direct effects of Z. Thus it is
reasonable to treat pτ20 as a constant.
We also assume, in addition to Assumption 2, that the variance of X
explained by the IVs is non-diminishing:
Assumption 5. ‖γ‖2 = Θ(1).
Theorem 4.1. In Model 2 and suppose Assumptions 1 and 3 to 5 hold,
p→∞ and p/n2 → 0. Then with probability going to 1 there exists a solution
of the APS equation such that (βˆ, pτˆ2) is in B. Furthermore, all solutions in
B are statistically consistent, i.e. βˆ p→ β0 and pτˆ2 − pτ20
p→ 0.
Next we consider the asymptotic distribution of the APS estimator.
Theorem 4.2. In Model 2 and under the assumptions in Theorem 4.1,
if additionally p = Θ(n) and ‖γ‖3/‖γ‖2 → 0, then
(4.4)
(
V˜ −12 V˜1V˜
−T
2
)1/2( βˆ − β0
τˆ2 − τ20
)
d→ N(0, I2),
where
V˜1 =
p∑
j=1
1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
(
(γ2j + σ
2
Xj)(σ
2
Y j + τ
2
0 ) + Γ
2
jσ
2
Xj 0
0 2(σ2Xj)
2
)
,
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V˜2 =
p∑
j=1
1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
(
γ2j (σ
2
Y j + τ
2
0 ) + Γ
2
jσ
2
Xj σ
2
Xjβ0
0 σ2Xj
)
.
Similar to Theorem 3.3, the information matrices V˜1 and V˜2 can be esti-
mated by substituting γ2j by γˆ
2
j − σ2Xj and Γ2j by Γˆ2j − σ2Y j − τˆ2. We omit
the details for brevity.
4.4. Example (continued). We apply the APS estimator to the BMI-
SBP example. Using the same 160 SNPs in Section 3.5, the APS point
estimate is βˆ = 0.301 (standard error 0.158) and τˆ2 = 9.2× 10−4 (standard
error 1.7× 10−4). Notice that the APS point estimate of β is much smaller
than the PS point estimate. One possible explanation of this phenomenon
is that the PS estimator tends to use a larger β to compensate for the
overdispersion in Model 2 (the variance of Γˆj−βγˆj is β2σ2Xj+σ2Y j in Model 1
and β2σ2Xj + σ
2
Y j + τ
2
0 in Model 2).
Figure 4 shows the diagnostic plots of the APS estimator. Compared to
the PS estimator in Section 3.5, the overdispersion issue is much more be-
nign. However, there is an outlier which corresponds to the SNP rs11191593.
It heavily biases the APS estimate too: when excluding this SNP, the APS
point estimate changes from 0.301 to almost 0.4 in the right panel of Figure 4.
The outlier might also inflate τˆ2 so the Q-Q plot looks a little underdispersed.
These observations motivate the consideration of a robust modification of
the APS in the next Section.
5. Idiosyncratic pleiotropy: Robustness to outliers. Next we con-
sider Model 3 with idiosyncratic pleiotropy. As mentioned in Section 3.4.1,
a single IV can have unbounded influence on the PS (and APS) estimators.
When the IV Zj has other strong causal pathways, its pleiotropy parameter
αj can be much larger than what is predicted by the random effects model
αj ∼ N(0, τ20 ), leading to a biased estimate of the causal effect as illustrated
in Section 4.4. In this Section, we propose a general method to robustify
the APS to limit the influence of outliers such as SNP rs11191593 in the
example.
5.1. Robustify the adjusted profile score. Our approach is an application
of the robust regression techniques pioneered by Huber [30]. As mentioned
in Section 3.1, the profile likelihood (3.2) can be viewed as a linear regression
of Γˆj on γˆj using the l2-loss. To limit the influence of a single IV, we consider
changing the l2-loss to a robust loss function. Two celebrated examples are
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Fig 4: Diagnostic plots of the Adjusted Profile Score (APS) estimator. Left
panel is a Q-Q plot of the standardized residuals against standard normal.
Right panel is the leave-one-out estimates against instrument strength.
the Huber loss
ρhuber(r; k) =
{
r2/2, if |r| ≤ k,
k(|r| − k/2), otherwise,
and Tukey’s biweight loss
ρtukey(r; k) =
{
1− (1− (r/k)2)3, if |r| ≤ k,
1, otherwise.
This heuristic motivates the following modification of the profile log-likelihood
when τ20 = 0:
(5.1) lρ(β) := −
p∑
j=1
ρ
(
Γˆj − βγˆj√
σ2Xjβ
2 + σ2Y j
)
It is easy to see that lρ(β) reduces to the regular profile log-likelihood (3.2)
if ρ(r) = r2/2.
When τ20 > 0, we cannot directly use the profile score (∂/∂τ
2)l(β, τ2) as
discussed in Section 4.1. This issue can be resolved using the APS approach
in Section 4.2 by using ψ2 in (4.3). However, a single IV can still have
unbounded influence in ψ2. We must further robustify ψ2, which is analogous
to estimating a scale parameter robustly.
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Next we briefly review the robust M-estimation of scale parameter. Con-
sider repeated measurements of a scale family with density f0(r/σ)/σ. Then
a general way of robust estimation of σ is to solve the following estimating
equation [36, Section 2.5]
Eˆ[(R/σ) · ρ′(R/σ)] = δ,
where Eˆ stands for the empirical average and δ = E[R · ρ′(R)] for R ∼ f0.
Based on the above discussion, we propose the following Robust Adjusted
Profile Score (RAPS) estimator of β. Denote
tj(β, τ
2) =
Γˆj − βγˆj√
σ2Xjβ
2 + σ2Y j + τ
2
.
Then the RAPS ψ(ρ) = (ψ
(ρ)
1 , ψ
(ρ)
2 ) is given by
ψ
(ρ)
1 (β, τ
2) =
p∑
j=1
ρ′(tj(β, τ2))uj(β, τ2),(5.2)
ψ
(ρ)
2 (β, τ
2) =
p∑
j=1
σ2Xj
tj(β, τ
2) · ρ′(tj(β, τ2))− δ
σ2Xjβ
2 + σ2Y j + τ
2
,(5.3)
where ρ′(·) is the derivative of ρ(·), uj(β, τ2) = −(∂/∂β)tj(β, τ2) and δ =
E[R ·ρ′(R)] for R ∼ N(0, 1). Notice that ψ(ρ) reduces to the non-robust APS
ψ in (4.2) and (4.3) when ρ(r) = r2/2 is the squared error loss. Finally,
the RAPS estimator (βˆ, τˆ2) is given by the non-trivial finite solution of
ψ(ρ)(β, τ2) = 0.
5.2. Asymptotics. Because the RAPS estimator is the solution of a sys-
tem of nonlinear equations, its asymptotic behavior is very difficult to ana-
lyze. For instance, it is difficult to establish statistical consistency because
there could be multiple roots for the RAPS equations in the population
level. Thus β might not be globally identified. We can, nevertheless, verify
the local identifiability [45]:
Theorem 5.1 (Local identification of RAPS). In Model 2, E[ψ(ρ)(β0, τ20 )] =
0 and E[∇ψ(ρ)] has full rank.
In practice, we find that the RAPS estimating equation usually only has
one finite solution. To study the asymptotic normality of the RAPS estima-
tor, we will assume (βˆ, pτˆ2) is consistent under Model 2. We further impose
the following smoothness condition on the robust loss function ρ:
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Assumption 6. The first three derivatives of ρ(·) exist and are bounded.
Theorem 5.2. In Model 2 and under the assumptions in Theorem 4.2,
if additionally we assume
1. the RAPS estimator is consistent: βˆ − β0 p→ 0, p(τˆ2 − τ20 )
p→ 0,
2. Assumption 6 holds, and
3. ‖γ‖33/‖γ‖32 = O(p−1/2),
then
(5.4)
(
(V˜
(ρ)
2 )
−1V˜ (ρ)1 (V˜
(ρ)
2 )
−T )1/2( βˆ − β0
τˆ2 − τ20
)
d→ N(0, I2),
where
V˜
(ρ)
1 =
(
c1(V˜1)11 0
0 c2(V˜1)22
)
,
V˜
(ρ)
2 =
(
δ(V˜2)11 δ(V˜2)12
0 [(δ + c3)/2](V˜2)22
)
,
and the constants are: for R ∼ N(0, 1), c1 = E[ρ′(R)2], c2 = Var(Rρ′(R))/2,
c3 = E[R2ρ′′(R)].
It is easy to verify that when ρ(r) = r2/2, δ = c1 = c2 = c3 = 1, so
V˜
(ρ)
1 and V˜
(ρ)
2 reduce to V˜1 and V˜2. In other words, the asymptotic variance
formula in Theorem 5.2 is consistent with the one in Theorem 4.2. However,
additional technical assumptions are needed in Theorem 5.2 to bound the
higher-order terms in the Taylor expansion.
5.3. Example (continued). As before, we illustrate the RAPS estimator
using the BMI-SBP example. Using the Huber loss with k = 1.345 (corre-
sponding to 95% asymptotic efficiency in the simple location problem), the
point estimate is βˆ = 0.378 (standard error 0.121), τˆ2 = 4.7×10−4 (standard
error 1.0× 10−4). Using the Tukey loss with k = 4.685 (also corresponding
to 95% asymptotic efficiency in the simple location problem), the point es-
timate is βˆ = 0.402 (standard error 0.106), τˆ2 = 3.4× 10−4 (standard error
7.8× 10−5).
Figure 5 shows the diagnostic plots of the two RAPS estimators. Com-
pared to Figure 4, the robust loss functions limit the influence of the out-
lier (SNP rs11191593), and the resulting βˆ becomes larger. In Figure 5b,
the outlier’s influence is essentially zero because the Tukey loss function
is redescending. This shows the robustness of our RAPS estimator to the
idiosyncratic pleiotropy.
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(a) RAPS using the Huber loss.
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(b) RAPS using the Tukey loss.
Fig 5: Diagnostic plots of the Robust Adjusted Profile Score (RAPS) es-
timator. Left panels are Q-Q plots of the standardized residuals against
standard normal. Right panels are the leave-one-out estimates against in-
strument strength.
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6. Simulation. Throughout the paper all of our theoretical results are
asymptotic. We usually require both the sample size n and the number of
IVs p to go to infinity (except for Theorem 3.2 where finite p is allowed).
We now assess if the asymptotic approximations are reasonably accurate in
practical situations, where p may range from tens to hundreds.
6.1. Simulating summary data directly from Assumption 1. To this end,
we first created simulated summary-data MR datasets that mimic the BMI-
SBP example in Section 1.2. In particular, we considered two scenarios:
p = 25, which corresponds to using the selection threshold 5 × 10−8 as de-
scribed in Section 1.2, and p = 160, which corresponds to using the threshold
1 × 10−4 as in Sections 3.5, 4.4 and 5.3. The model parameters are chosen
as follows: the variances of the measurement error, {(σ2Xj , σ2Y j)}j∈[p], are the
same as those in the BMI-SBP dataset. The true marginal IV-exposure ef-
fects, {γj}j∈[p], are chosen to be the observed effects in the BMI-SBP dataset,
and γˆj is generated according to Assumption 1 by γˆj
ind.∼ N(γj , σ2Xj). The
true marginal IV-outcome effects, {Γj}j∈[p], are generated in six different
ways with β0 = 0.4:
1. Γj = γjβ0;
2. Γj = γjβ0 + αj , αj
i.i.d.∼ N(0, τ20 ), where τ0 = 2 · (1/p)
∑p
j=1 σY j ;
3. Γj is generated according to setup 2 above, except that α1 has mean
5 · τ0 (the IVs are sorted so that the first IV has the largest |γj |/σXj).
4. Γj = γjβ0 +αj , αj
i.i.d.∼ τ0 ·Lap(1), where Lap(1) is the Laplace (double
exponential) distribution with rate 1.
5. Γj = γjβ0 + αj , αj = |γj |/(p−1
∑p
j=1 |γj |) ·N(0, τ20 ).
6. Γj is generated according to setup 2 above, except that for 10% ran-
domly selected IVs, their direct effects αj have mean 5 · τ0.
The first three setups correspond to Models 1 to 3, respectively, and the last
three setups violate our modeling assumptions and are used to assess the
robustness of the procedures. Finally, Γˆj is generated according to Assump-
tion 1 by Γˆj
ind.∼ N(Γj , σ2Y j).
We applied six methods to the simulated data (10,000 replications in each
setting). The first three are existing methods to benchmark our performance:
the inverse variance weighting (IVW) estimator [13], MR-Egger regression
[7], and the weighted median estimator [8]. The next three methods are
proposed in this paper: the profile score (PS) estimator in Section 3, the
adjusted profile score (APS) estimator in Section 4, and the robust adjusted
profile score (RAPS) estimator in Section 5 with Tukey’s loss function (k =
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4.685).
The simulation results are reported in Table 1 for p = 25 and Table 2 for
p = 160. Here is a summary of the results:
1. In setup 1, the PS estimator has the smallest root-median square error
(RMSE) and the shortest confidence interval (CI) with the desired
coverage rate. The IVW estimator performs very well when p = 25 but
has considerable bias and less than nominal coverage when p = 160.
The APS and RAPS estimators have slightly longer CI than PS. The
MR-Egger and weighted median estimators are less accurate than the
other methods.
2. In setup 2, the PS estimator, as well as the weighted median, have
substantial bias and perform poorly. The APS estimator is overall the
best with very small bias and desired coverage, followed very closely
by RAPS. The IVW and MR-Egger estimators also perform quite well,
though their relative biases are more than 10% when p = 160.
3. In setup 3, all estimators besides RAPS have very large bias and poor
CI coverage. The RMSE of the RAPS estimator is slightly larger than
the RMSE in Model 2, and the coverage of RAPS is slightly below the
nominal rate.
4. In setup 4, the direct effects αj are distributed as Laplace instead of
normal. The RAPS estimator has the smallest bias and RMSE, though
the coverage is slightly below the nominal level.
5. In setup 5, the variance of αj is proportional to |γj |. In this case APS
and RAPS are approximately unbiased but the coverage is significantly
lower than 95%.
6. In setup 6, 10% of the IVs have very large but roughly balanced
pleiotropy effects αj . All estimators are biased in this case. The RAPS
estimator has the smallest RMSE but the CI coverage is slightly below
95%. The IVW and APS estimators have slightly larger RMSE and
the CI has the desired coverage rate.
Finally, we briefly remark on the bias of IVW and other existing estima-
tors. In 3.3 we have derived that the IVW estimator is biased towards 0
and the relative bias is approximately 1/κ. The average instrument strength
κ in the two settings are κ = 33.1 (p = 25) and κ = 9.1 (p = 160). The
simulation results for setup 1 in Tables 1 and 2 almost exactly match the
prediction from our approximation formula (3.10).
Overall, the RAPS estimator is the clear winner in this simulation: when
there is no idiosyncratic outlier (setups 1 and 2), it behaves almost as well
as the best performer; when there is an idiosyncratic outlier (setup 3), it
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Table 1
Simulation results for p = 25. The summary statistics reported are: bias divided by β0,
root-median-square error (RMSE) divided by β0, length of the confidence interval (CI)
divided by β0, and the coverage rate of the CI (nominal rate is 95%), all in %.
Setup Method Bias % RMSE % CI Len. % Cover. %
1 IVW − 2.9 12.7 73.8 95.4
Egger − 7.4 24.4 142.3 95.3
W. Median − 5.2 17.0 105.5 96.5
PS − 0.1 12.7 74.9 95.1
APS − 0.4 12.7 76.8 96.0
RAPS − 0.4 13.0 79.0 96.1
2 IVW − 3.0 29.3 167.9 93.3
Egger − 8.2 59.7 319.2 92.1
W. Median − 12.8 39.9 121.4 70.6
PS 14.7 36.1 71.4 49.2
APS − 0.2 28.8 165.4 93.4
RAPS − 0.1 30.1 170.2 93.1
3 IVW −115.5 115.2 225.6 48.1
Egger −264.2 262.8 409.1 25.5
W. Median − 80.7 79.5 151.4 47.3
PS −122.3 121.3 66.1 6.9
APS − 86.2 85.6 207.0 65.0
RAPS − 11.6 40.6 168.7 84.3
4 IVW − 5.1 25.1 159.5 96.0
Egger − 54.5 58.8 300.9 90.0
W. Median − 22.5 26.0 113.2 83.8
PS 13.4 31.2 71.7 55.9
APS 4.0 25.6 158.4 96.1
RAPS 2.6 20.3 117.5 93.3
5 IVW − 2.4 48.2 169.7 76.3
Egger − 8.2 98.0 321.0 72.9
W. Median − 24.4 60.4 136.7 56.0
PS 15.8 57.2 71.6 33.0
APS 0.9 46.8 183.0 81.1
RAPS 1.5 44.9 169.0 78.3
6 IVW − 8.1 64.2 382.8 94.8
Egger −102.2 134.8 723.7 90.7
W. Median − 30.8 50.3 130.6 63.1
PS 200.2 309.6 82.1 4.1
APS 13.7 62.1 327.1 92.8
RAPS 12.3 50.3 298.2 85.4
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Table 2
Simulation results for p = 160. The summary statistics reported are: bias divided by β0,
root-median-square error (RMSE) divided by β0, length of the confidence interval (CI)
divided by β0, and the coverage rate of the CI (nominal rate is 95%), all in %.
Setup Method Bias % RMSE % CI Len. % Cover. %
1 IVW − 11.1 12.2 51.0 87.0
Egger − 10.1 15.2 79.9 92.6
W. Median − 12.6 15.6 84.3 93.9
PS 0.1 9.6 57.0 95.2
APS − 0.4 9.5 58.3 95.8
RAPS − 0.5 9.8 59.9 95.8
2 IVW − 11.6 23.2 122.5 92.6
Egger − 10.8 34.9 191.5 93.6
W. Median − 25.7 34.3 105.5 68.9
PS 119.2 119.8 51.0 6.2
APS − 0.4 23.0 134.8 95.1
RAPS − 0.4 23.8 138.7 95.1
3 IVW − 70.1 69.9 131.3 44.7
Egger − 125.5 125.6 203.8 32.3
W. Median − 65.0 65.0 111.5 41.5
PS 4.1 77.9 44.6 15.5
APS − 47.9 48.3 139.3 73.2
RAPS − 3.9 27.4 137.9 90.6
4 IVW − 11.9 20.5 121.5 94.7
Egger − 13.6 31.5 189.5 94.7
W. Median − 24.1 24.8 93.9 80.2
PS 134.7 114.3 51.4 7.1
APS 4.8 20.8 133.6 96.5
RAPS 4.3 16.1 91.3 93.6
5 IVW − 11.0 53.9 139.7 62.2
Egger − 9.8 92.5 217.7 56.9
W. Median − 56.0 63.7 125.2 49.3
PS − 819.8 244.0 57.8 4.7
APS − 0.3 55.3 170.7 71.6
RAPS 1.5 48.6 120.4 59.8
6 IVW − 12.7 47.2 278.8 95.0
Egger − 16.4 74.2 435.3 94.9
W. Median − 34.9 43.6 115.2 63.1
PS > 999.9 > 999.9 > 999.9 12.8
APS 13.6 50.2 291.2 95.2
RAPS 10.8 42.7 258.4 91.2
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still has very small bias and close-to-nominal coverage; when our modeling
assumptions are not satisfied (setups 4, 5, 6), it still has the smallest bias
and RMSE, though the CI may fail to cover β0 at the nominal rate.
6.2. Simulating from real genotypes. As pointed out by an anonymous
reviewer, the marginal GWAS coefficients might not perfectly follow the dis-
tributional assumptions in Assumption 1. In fact, in Section 2.2 we already
showed that even in linear structural models the marginal coefficients have
small but non-zero covariances. As a proof of concept, we perform another
simulation study using real genotypes from the 1000 Genomes Project [16].
In total, the 1000 Genomes Project phase 1 dataset contains the geno-
types of 1092 individuals. We simulated the exposure X and outcome Y
according to the linear structural equation model (2.3) using the entire 10th
chromosome as Z (containing 1, 882, 663 genetic variants). 100 random en-
tries of γ are set to be non-zero and follow the Laplace distribution with
rate 1. The unmeasured confounder U is simulated from the standard nor-
mal distribution and the parameters were set to ηX = 3, ηY = 5. The noise
variables were simulated from EX ∼ N(0, 32) and EY ∼ N(0, 52). The di-
rect effects α had pα random non-zero entries that were simulated from the
Laplace distribution with rate rα. In total we considered five settings:
1. β = 0, pα = 0;
2. β = 0, pα = 200, rα = 0.5;
3. β = 1, pα = 0;
4. β = 1, pα = 200, rα = 0.5;
5. β = 1, pα = 200, rα = 1.5;
In this dataset, 368, 977 variants have minor allele frequency greater 5%
and are considered as potential instrumental variables. We used 292, 400
and 400 individuals (random partition) as the selection, exposure and out-
come data and obtained GWAS summary data by running marginal linear
regressions. We simulated Y using one of the five settings described above.
After LD clumping (p-value ≤ 5× 10−3), 121 independent variants were se-
lected as IVs, and we applied existing and our methods to these 121 SNPs.
To provide a more comprehensive comparison, we also applied two classical
IV estimator, two-stage least squares (2SLS) and limited information max-
imum likelihood (LIML), to the outcome sample of 400 individuals. For the
LIML estimator we computed the standard error using the “many weak IV
asymptotics” [25]. Note that 2SLS and LIML cannot be computed using just
the GWAS summary data and they assume all the IVs are valid.
We used 5, 000 replications to obtain the same performance metrics in
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Section 6.1, which are reported in Table 3. Overall, our estimators (in par-
ticular, APS and RAPS) are unbiased and maintain the nominal CI coverage
rate in all 5 settings. The three existing estimators—IVW, MR-Egger, and
weighted median—are heavily biased towards 0 when β 6= 0. Also, notice
that their RMSE and CI length are (abnormally) smaller than the RMSE
and CI length of the “oracle” LIML estimator that uses individual geno-
types. The 2SLS estimator is heavily biased due to weak instruments.
Although the simulation results in Table 3 are encouraging, we want to
point out that the sample size and simulation parameters we used might be
quite different from actual MR studies. The pleiotropy models (parametrized
by pα and rα) being tested here are also limited. Nonetheless, this simulation
shows that using the statistical framework developed in this paper, it is
possible to obtain summary-data MR estimators that perform almost as
well as the “oracle” LIML estimator that uses individual data.
7. Comparison in real data examples.
7.1. In the BMI-SBP example. Table 4 briefly summarize the results
using different estimators in this and previous papers for the BMI-SBP ex-
ample introduced in Section 1.2. Since the ground truth is unknown, we
do not know which estimate is closer to the truth. Nevertheless, we can
still make two observations. First, the point estimates varied considerably
between the methods, so the choice of estimator may make a difference in
practice. Second, the PS, IVW, and MR-Egger point estimates changed sub-
stantially when all 160 SNPs were used instead of just the 25 strongest ones,
whereas the RAPS estimators and the weighted median were more stable.
7.2. An illustration of weak IV bias and selection bias. Finally, we con-
sider another real data validation example, which shall be referred to as the
BMI-BMI example. In this example, both the “exposure” and the “outcome”
are BMI. Although there is no “causal” effect of BMI on itself, Model 1 for
GWAS summary data should technically hold with β0 = 1. Therefore, this
is a rare scenario where we know the truth in real data. Since there are
many SNPs that are only weakly associated with BMI, this example also
offers a good opportunity to probe the issue of weak instrument bias and
the efficiency gain by including many weak IVs. The downside is that this
example does not test the methods’ robustness to pleiotropy because the
exposure and outcome are the same trait.
We obtained three GWAS datasets for this example:
BMI-GIANT: full dataset from the GIANT consortium [35] (i.e. combining
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Table 3
Results for the numerical simulation using real genotypes. The performance metrics
reported are: bias (median βˆ minus β), root-median-square error (RMSE), median length
of the confidence interval (CI), and the coverage rate of the CI (nominal rate is 95%).
Setup Method Bias RMSE CI Len. Coverage %
1 IVW 0.00 0.08 0.42 93.1
Egger 0.00 0.11 0.62 95.1
W. Median 0.00 0.12 0.74 96.8
PS 0.01 0.26 1.42 92.9
APS 0.01 0.23 1.61 98.9
RAPS 0.00 0.23 1.76 98.2
2SLS −0.46 0.46 0.41 0.9
LIML 0.00 0.26 1.40 94.5
2 IVW −0.02 0.08 0.45 94.0
Egger −0.02 0.11 0.65 95.4
W. Median −0.04 0.12 0.78 97.2
PS −0.06 0.29 1.42 89.2
APS −0.05 0.25 1.67 98.6
RAPS −0.05 0.25 1.82 97.5
2SLS −0.47 0.47 0.43 1.1
LIML 0.02 0.28 1.56 95.4
3 IVW −0.63 0.63 0.43 0.1
Egger −0.45 0.45 0.61 21.1
W. Median −0.64 0.64 0.76 8.7
PS 0.08 0.22 1.35 96.9
APS 0.02 0.22 1.78 97.6
RAPS 0.01 0.22 1.87 93.1
2SLS −0.46 0.46 0.41 1.2
LIML −0.01 0.26 1.41 94.8
4 IVW −0.65 0.65 0.46 0.2
Egger −0.47 0.47 0.65 22.4
W. Median −0.61 0.61 0.79 13.6
PS 0.13 0.26 1.39 95.1
APS 0.01 0.25 1.86 96.6
RAPS −0.01 0.24 1.95 92.2
2SLS −0.46 0.46 0.43 1.4
LIML 0.03 0.28 1.57 95.4
5 IVW −0.68 0.68 0.62 0.9
Egger −0.50 0.50 0.90 40.4
W. Median −0.44 0.44 0.97 57.0
PS 0.41 0.49 1.72 87.3
APS 0.01 0.37 2.40 96.8
RAPS −0.04 0.33 2.48 94.8
2SLS −0.47 0.47 0.57 10.4
LIML 0.23 0.51 2.93 97.9
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Table 4
Comparison of results in the BMI-SBP example.
Method
p = 25 p = 160
βˆ SE βˆ SE
PS 0.367 0.075 0.601 0.054
APS 0.364 0.133 0.301 0.158
RAPS (Huber) 0.354 0.131 0.378 0.121
RAPS (Tukey) 0.361 0.133 0.402 0.106
IVW 0.332 0.140 0.514 0.102
MR-Egger 0.647 0.283 0.472 0.176
Weighted median 0.516 0.125 0.514 0.102
BMI-FEM and BMI-MAL), used to select SNPs.
BMI-UKBB-1: half of the UKBB data, used as the “exposure”.
BMI-UKBB-2: another half of UKBB data, used as the “outcome”.
We applied in total six methods. Four have been previously developed:
besides the three estimators considered in Section 6, we also included the
weighted mode estimator of Hartwig, Davey Smith and Bowden [26]. We
use the implementation in the TwoSampleMR software package [28] for the
existing methods. The last two methods were the PS and RAPS estimators
developed in this paper (APS performs similarly to PS and RAPS and is
omitted).
The results are reported in Table 5. Overall, the PS and RAPS estimators
provided very accurate estimate of β0 = 1. PS has the smallest standard
error because there is no pleiotropy at all in this example. When there is
pleiotropy (as expected in most real studies), PS can perform poorly as
demonstrated in Section 6. All the existing methods are biased especially
when there are many weak IVs.
In Table 6 we illustrate the danger of selection bias. In this example we
discard the BMI-GIANT dataset and use BMI-UKBB-1 for both selection and
inference (estimating γj). The estimators are biased towards 0 in almost
all cases, even if we only use the genome-wide significant p-value threshold
10−9 or 10−8. This is because the assumption γˆj ∼ N(γj , σ2Xj) is violated.
In fact, due to selection bias, the selected γˆj are stochastically larger than
their mean γj (if γj > 0). Compared with other methods, the MR-Egger
regression seems to be less affected by the selection bias.
8. Discussion. In this paper we have proposed a systematic approach
for two-sample summary-data Mendelian randomization based on modifying
the profile score function. By considering increasingly more complex models,
MENDELIAN RANDOMIZATION BY RAPS 33
Table 5
Results of the BMI-BMI example. The true β0 should be 1. We considered 8 selection
thresholds psel from 1 × 10−9 to 1× 10−2. The mean and median of the F -statistics
γˆ2j /σ
2
Xj are reported. In each setting, we report the point estimate and the standard error
of all the methods.
psel # SNPs Mean F IVW W. Median W. Mode
1e-9 48 78.6 0.983 (0.026) 0.945 (0.039) 0.941 (0.042)
1e-8 58 69.2 0.983 (0.024) 0.945 (0.039) 0.939 (0.044)
1e-7 84 55.0 0.988 (0.024) 0.945 (0.036) 0.933 (0.041)
1e-6 126 44.1 0.986 (0.022) 0.944 (0.034) 0.931 (0.038)
1e-5 186 34.3 0.986 (0.019) 0.943 (0.033) 0.928 (0.039)
1e-4 287 26.1 0.981 (0.017) 0.941 (0.031) 0.929 (0.035)
1e-3 474 18.8 0.955 (0.015) 0.903 (0.027) 0.917 (0.231)
1e-2 812 12.7 0.928 (0.014) 0.879 (0.023) 0.739 (7.130)
psel # SNPs Median F Egger PS RAPS
1e-9 48 51.8 0.926 (0.055) 0.999 (0.023) 0.998 (0.026)
1e-8 58 42.0 0.928 (0.050) 0.999 (0.023) 0.998 (0.025)
1e-7 84 32.1 0.905 (0.048) 1.012 (0.021) 1.004 (0.025)
1e-6 126 27.4 0.881 (0.043) 1.017 (0.019) 1.009 (0.023)
1e-5 186 21.0 0.874 (0.036) 1.020 (0.018) 1.013 (0.020)
1e-4 287 15.8 0.921 (0.031) 1.023 (0.017) 1.018 (0.018)
1e-3 474 10.8 0.913 (0.027) 1.010 (0.016) 1.006 (0.016)
1e-2 812 5.6 0.909 (0.022) 1.010 (0.015) 1.005 (0.015)
we arrived at the Robust Adjusted Profile Score (RAPS) estimator which is
robust to both systematic and idiosyncratic pleiotropy and performed excel-
lently in all the numerical examples. Thus we recommend to routinely use
the RAPS estimator in practice, especially if the exposure and the outcome
are both complex traits.
Our theoretical and empirical results advocate for a new design of two-
sample MR. Instead of using just a few strong SNPs (those with large
|γˆj |/σXj), we find that adding many (potentially hundreds of) weak SNPs
usually substantially decreases the variance of the estimator. This is not
feasible with existing methods for MR because they usually require the in-
struments to be strong. An additional advantage of using many weak instru-
ments is that outliers in the sense of Model 3 are more easily detected, so
the results are generally more robust to pleiotropy. There is one caveat: se-
lection bias is more significant for weaker instruments, so a sample-splitting
design (such as the one in Section 1.2) should be used.
In Models 2 and 3, we have assumed that the pleiotropy effects are com-
pletely independent and normally or nearly normally distributed. We view
this assumption as an approximate modeling assumption rather than the
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Table 6
Illustration of selection bias. The same BMI-UKBB-1 dataset is used for both selecting
SNPs and estimating the SNP-exposure effects γj. All estimators are biased (true β0 = 1)
due to not accounting for selection bias.
psel # SNPs Mean F IVW W. Median W. Mode
1e-9 110 68.63 0.851 (0.02) 0.83 (0.025) 0.896 (0.046)
1e-8 168 57.00 0.823 (0.017) 0.8 (0.022) 0.885 (0.053)
1e-7 228 50.08 0.799 (0.016) 0.768 (0.019) 0.886 (0.058)
1e-6 305 43.92 0.761 (0.015) 0.736 (0.019) 0.865 (0.079)
1e-5 443 36.98 0.721 (0.013) 0.667 (0.016) 0.824 (0.12)
1e-4 652 30.68 0.678 (0.012) 0.616 (0.015) 0.593 (0.122)
1e-3 929 25.36 0.629 (0.011) 0.57 (0.014) 0.576 (0.096)
1e-2 1289 20.70 0.592 (0.01) 0.528 (0.013) 0.554 (0.093)
psel # SNPs Median F Egger PS RAPS
1e-9 110 49.20 1.071 (0.051) 0.871 (0.015) 0.862 (0.021)
1e-8 168 41.12 1.018 (0.046) 0.848 (0.014) 0.831 (0.018)
1e-7 228 37.12 1.016 (0.043) 0.824 (0.012) 0.803 (0.016)
1e-6 305 33.68 1.006 (0.041) 0.793 (0.011) 0.763 (0.016)
1e-5 443 28.74 0.957 (0.037) 0.762 (0.01) 0.716 (0.015)
1e-4 652 23.23 0.89 (0.033) 0.724 (0.009) 0.66 (0.014)
1e-3 929 19.12 0.823 (0.03) 0.687 (0.008) 0.594 (0.013)
1e-2 1289 15.26 0.749 (0.025) 0.657 (0.008) 0.541 (0.012)
precise data generating mechanism. It is motivated by the real data (Sec-
tion 3.5) and seems to fit the data very well (Section 5.3). It is a special
instance of the INstrument Strength Independent of Direct Effect (INSIDE)
assumption [10] that is common in the summary-data MR literature. Apart
from normality, two other implicit but key assumptions we made are:
1. The pleiotropy effects αj are additive rather than multiplicative (the
variance of αj is proportional to σY j) [7]. Multiplicative random ef-
fects model are easier to fit especially if the measurement error in γˆj
is ignored, however it is quite unrealistic because αj is a population
quantity and thus is unlikely to be dependent on a sample quantity (for
example, σY j may vary due to missing data). In contrast, the additive
model is well motivated by the linear structural model in 2.3.
2. The pleiotropy effects αj have mean 0. In comparison, the MR-Egger
regression [7] assumes αj has an unknown mean µ and refers to the case
µ 6= 0 as “directional pleiotropy”. We have not seen strong evidence
of “directional pleiotropy” in real datasets, and, more importantly,
assuming µ 6= 0 implies that there is a “special” allele coding so that
αj ∼ N(µ, τ2). It is thus impossible to obtain estimators of β that
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are invariant to allele recoding without completely reformulating the
MR-Egger model. For further details see Bowden et al. [11].
There are many technical challenges in the development of this paper.
Due to the nature of the many weak IV problem, the asymptotics we con-
sidered are quite different from the classical measurement error literature. In
Section 3 we showed the profile likelihood is information biased when there
are many weak IVs, and in Section 4.1 we showed the profile likelihood is
biased when there is overdispersion caused by systematic pleiotropy. This
issue is solved by adjusting the profile score, but the proof of the consistency
of the APS estimator is nontrivial. Consistency of the the RAPS estimator is
even more challenging and still open because the estimating equations may
have multiple roots, although we found its practical performance is usually
quite benign. A possible solution is to initialize by another robust and con-
sistent estimator (similar to the MM-estimation in robust regression, see
Yohai [56]). However, we are not aware of any other provably robust and
consistent estimator in our setting, and deriving such estimator is beyond
the scope of this paper.
Software and reproducibility. R code for the methods proposed in
this paper can be found in the package mr.raps that is publicly available
at https://github.com/qingyuanzhao/mr.raps and can be directly called
from TwoSampleMR. Numerical examples can be reproduced by running ex-
amples in the R package.
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APPENDIX A: LINEAR MODEL FOR GWAS SUMMARY DATA
In this Appendix we give additional justifications of the linear model (1.1)
for GWAS summary data. We will show (1.1) is very likely to hold in very
general situations, much beyond the linear structural model considered in
Section 2.
A.1. Binary outcome and logistic model. When the outcome Y is
binary, the linear structural model (2.2) is no longer appropriate. Instead,
we consider the following logistic model of Y (let H(t) = 1/(1 + e−t) be the
logistic link function):
(A.1) X =
p∑
j=1
γjZj + ηXU + EX , Y ∼ Bernoulli
(
H(βX + ηY U)
)
.
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Next we derive an approximation of the coefficient Γj when we run a
logistic regression of Y on Zj . By (A.1), we have
P(Y = 1|Zj = zj) = E
[
H
(
βγjzj + E
′)],
where E′ = β
∑
k 6=j γkZk+βηXU+βEX+ηY U . If we assume E
′ ∼ N(µ, σ2j ),
then
P(Y = 1|Zj = zj) =
∫ ∞
−∞
H
(
µ+ βγjzj + σje
)
φ(e) de.
Note that σ2j ≈ σ2 = Var(βX + ηY U) when γj is small.
To proceed further we introduce a well-known probit approximation of
logistic function [15]:
H(t) ≈ Φ(t/1.7).
By using the following Gaussian integral identity,∫ ∞
−∞
Φ(a+ bx)φ(x) dx = Φ
(
a√
1 + b2
)
,
we obtain
P(Y = 1|Zj = zj) ≈
∫ ∞
−∞
Φ
(
µ+ βγjzj + σe
1.7
)
φ(e) de
= Φ
(
µ+ βγjzj
1.7
√
1 + (σ/1.7)2
)
≈ H
(
µ+ βγjzj√
1 + (σ/1.7)2
)
.
Therefore Γj ≈ βγj/
√
1 + (σ/1.7)2. In other words, model (1.1) is approxi-
mately correct with β0 = β/
√
1 + (σ/1.7)2. The attenuation bias is due to
the non-collapsibility of odds ratio [? ]. Notice that although we assumed
E′ is normally distributed in our calculation, this approximation is quite
accurate for many other distributions [15, Section 4.8.2]. A similar result
can be found in ? ] who also discussed the general intepretation of causal
odds ratios.
A.2. General situation: a local argument. The linear model (1.1)
may actually hold in much broader situations than the linear and logistic
models considered above. The main reason is that for most SNPs, the influ-
ence on a complex trait X is usually minuscule [12, 31, 41, 46]. Let’s consider
a continuous exposure X and the quantity E[h(Y )|Zj = 1]−E[h(Y )|Zj = 0]
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for some function h of interest. Assuming appropriate differentiability and
using the shorthand notation X(z1) = g(z1, Z2, . . . , Zp, U,EX), we have,
E[h(Y )|Z1 = 1]− E[h(Y )|Z1 = 0]
=E
[
h
(
f(X(1), U,EY )
)− h(f(X(0), U,EY ))]
≈E[h′(f (1)(X,U,EY )) · (X(1)−X(0))],
where h′ is th derivative of h and f (1) is the partial derivative of f with
respect to its first argument. In this approximation we have used the as-
sumption that X(1)−X(0) is small, i.e. the exposure X is not changed by
a single instrument Z1 by much.
In many epidemiological problems, the causal effect of X on the outcome
Y is also very small compared to the variance of Y . Therefore, when it
is reasonable to assume that the variability of the term f (1)(X,U,EY ) is
mostly driven by the noise variable EY which is independent of X(0) and
X(1), we have
E[h(Y )|Z1 = 1]− E[h(Y )|Z1 = 0] ≈ E[h′(f (1)(X,U,EY ))] · E[X(1)−X(0)].
The left hand side of the above equation may be regarded as a general
version of Γ1 and E[X(1) − X(0)] a general version of γ1. Thus we arrive
at the approximation Γ1 ≈ β0γ1 for β0 = E[h′(f (1)(X,U,EY ))]. This may
be interpreted as the average of “local” causal effect: let h be the identity
function and write the potential outcome Y (x) = f(x, U,EY ), then
β0 ≈ lim
∆x→0
E[Y (X + ∆x)− Y (X)]
∆x
,
where the expectation is taken jointly over X, U , and EY .
The above local argument reflects a meta-analysis interpretation of MR
[7]: each SNP can be viewed as randomized experiment that changes the
exposure X by just a little. Because all the changes are relatively small
compared to the variability of X and Y , the relationship between γj and
Γj is almost linear. This is why we expect the approximate linear relation
(1.1) may hold in many problems beyond those discussed in Section 2.2
and Appendix A.1.
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APPENDIX B: PROOFS
B.1. Proof of Theorem 3.1. Notice that by Assumption 2, p/(n2‖γ‖22)→
0 implies that n→∞. Let ej = Γˆj−Γj and j = γˆj−γj . After some algebra,
we have
l(β) = −1
2
p∑
j=1
γ2j (β0 − β)2 + (ej − βj)2 + 2γj(β0 − β)(ej − βj)
σ2Xjβ
2 + σ2Y j
.
Notice that ej−βj ∼ N(0, σ2Xjβ2 +σ2Y j). By Assumption 3, suppose σ2Xj ≥
cσ/n and σ
2
Y j ≥ cσ/n for all j ∈ [p]. Using the elementary inequality 2/(a+
b) ≥ min(1/a, 1/b) for a, b > 0, we obtain
− 2l(β)
=(β0 − β)2
[ p∑
j=1
γ2j
σ2Xjβ
2 + σ2Y j
]
+ p+Op
(√
p+
√
n‖γ‖ · |β0 − β|
)
≥1
2
(β0 − β)2 min
( p∑
j=1
γ2j
σ2Y j
,
p∑
j=1
γ2j
σ2Xjβ
2
)
+ p+Op
(√
p+
√
n‖γ‖ · |β0 − β|
)
≥n‖γ‖
2
2
2cσ
min
(
(β0 − β)2, (β0 − β)
2
β2
)
+ p+Op
(√
p+
√
n‖γ‖ · |β0 − β|
)
Consider the case β0 > 0. By taking derivative, it is easy to verify that
f(β) = (β0 − β)2/β2 is decreasing in β when 0 < β < β0 and increasing in
β when β < 0 or β > β0. Since f(β) → 1 as |β| → ∞, for any  > 0 there
exists constant C(β0, ) > 0 such that inf |β−β0|≥(β0 − β)2/β2 ≥ C(β0, ).
Similarly, we can show this is also true for β0 < 0 and β0 = 0. Also, notice
that the last term Op(
√
n|β0 − β|) is negligible compared to the first term
when |β − β0| ≥ . Let C ′(β0, ) = min(2, C(β0, )) > 0. We have
inf
|β−β0|≥
−2l(β) ≥ (1 + op(1))C ′(β0, )n‖γ‖
2
2
2cσ
+ p+Op
(√
p
)
.
Finally, by comparing this to −2l(β0) = p+Op(√p), we have
P
(
l(β0) > sup
|β−β0|≥
l(β)
)
= P
(
Op(
√
p) ≤ (1 + op(1))C ′(β0, )n‖γ‖
2
2
2cσ
+Op
(√
p
))
.
When p n2‖γ‖4, it is easy to see that this probability converges to 1.
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B.2. Proof of Theorem 3.2. By (3.6) and the consistency of βˆ, we
have
βˆ − β0 = −ψ(β0)
ψ′(β0) + (1/2)ψ′′(β˜)(βˆ − β0)
=
V2√
V1
· −ψ(β0)/
√
V1
[ψ′(β0) + op(ψ′′(β˜))]/V2
The central limit theorem Equation (3.7) is immediately proven using
Slutsky’s lemma after showing the following three lemmas:
Lemma B.1. (1/
√
V1)ψ(β0)
d→ N(0, 1).
Lemma B.2. (−1/V2)ψ′(β0) p→ 1.
Lemma B.3. For a neighborhood N of β0, supβ∈N (1/V2)ψ′′(β) = Op(1).
Next we prove the three lemmas. For the first lemma, let ψj(β) be the
j-th summand in (3.5), so ψ(β) =
∑p
j=1 ψj(β). It is easy to show that
(B.1) ψj(β0) =
(ej − β0j)[γj(σ2Y j + σ2Xjβ20) + ejσ2Xjβ0 + jσ2Y j ]
(σ2Y j + σ
2
Xjβ
2
0)
2
.
The expectation of ψj(β0) is
E[ψj(β0)] =
E[e2jσ2Xjβ0 − 2jσ2Y jβ0]
(σ2Y j + σ
2
Xjβ
2
0)
2
= 0.
This shows that E[ψ(β0)] = 0. The second moment of ψj(β0) is given by
E[ψj(β0)2] = Aj +Bj ,
where
Aj = E
[
(ej − β0j)2γ2j (σ2Y j + σ2Xjβ20)2
(σ2Y j + σ
2
Xjβ
2
0)
4
]
=
γ2j
σ2Y j + σ
2
Xjβ
2
0
,
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and
Bj = E
[
(ej − β0j)2(ejσ2Xjβ0 + jσ2Y j)2
(σ2Y j + σ
2
Xjβ
2
0)
4
]
= E
[
e4jσ
4
Xjβ
2
0 + 
4
jσ
4
Y jβ
2
0 + e
2
j
2
j (σ
4
Y j − 4β0σ2Xjβ0σ2Y j + β20σ4Xjβ20)
(σ2Y j + σ
2
Xjβ
2
0)
4
]
=
3σ4Y jσ
4
Xjβ
2
0 + 3σ
4
Xjσ
4
Y jβ
2
0 + σ
2
Y jσ
2
Xj(σ
4
Y j − 4β0σ2Xjβ0σ2Y j + β20σ4Xjβ20)
(σ2Y j + σ
2
Xjβ
2
0)
4
=
σ2Y jσ
2
Xj(σ
4
Y j + 2β
2
0σ
2
Xjσ
2
Y j + β
4
0σ
4
Xj)
(σ2Y j + σ
2
Xjβ
2
0)
4
=
σ2Xjσ
2
Y j
(σ2Y j + σ
2
Xjβ
2
0)
2
.
In summary,
E[ψj(β0)2] =
γ2j σ
2
Y j + Γ
2
jσ
2
Xj + σ
2
Xjσ
2
Y j
(σ2Y j + σ
2
Xjβ
2
0)
2
.
Notice that by Assumption 3, E[ψj(β0)2] = Θ(nγ2j + 1).
To prove Lemma B.1, we consider two scenarios:
Scenario 1: p → ∞. In this case, we hope to use central limit theorem to
show
1√
V1
ψ(β0) =
1√
V1
p∑
j=1
ψj(β0)→ N(0, 1).
Next we check Lyapunov’s condition by computing the third moment of
ψj(β0). Notice that
E[|ψj(β0)|3] =
E
{∣∣(ej − β0j)3[γj(σ2Y j + σ2Xjβ20) + ejσ2Xjβ0 + jσ2Y j ]3∣∣}
(σ2Y j + σ
2
Xjβ
2
0)
6
=
E[|C0 + C1γj + C2γ2j + C3γ3j |]
(σ2Y j + σ
2
Xjβ
2
0)
6
≤ E[|C0|] + γjE[|C1|] + γ
2
jE[|C2|] + γ3jE[|C3|]]
(σ2Y j + σ
2
Xjβ
2
0)
6
We omit the detailed expressions for C0, C1, C2 and C3 but note that there
exists constant C(β0) > 0 such that E[|Ci|] ≤ C(β0)(1/n)6−i/2 for i =
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0, 1, 2, 3. Therefore
p∑
j=1
E[|ψj(β0)|3] = O(p+
√
n‖γ‖1 + n‖γ‖22 + n3/2‖γ‖33).
By the Cauchy-Schwarz inequality,
√
n‖γ‖1 ≤
√
n
√
p‖γ‖2 ≤ (p+n‖γ‖22)/2.
Using the assumption ‖γ‖3/‖γ‖2 → 0, it is easy to show the Lyapunov
condition ∑p
j=1 E[|ψj(β0)|3]{∑p
j=1 E[ψj(β0)2]
}3/2 = O(p+ n‖γ‖22 + n3/2‖γ‖33(p+ n‖γ‖22)3/2
)
→ 0.
Scenario 2: p is finite. By the assumption in the Theorem statement, κ =
n‖γ‖22/p→∞. We can rewrite (B.1) to obtain
ψ(β0) =
p∑
j=1
(ej − β0j)γj
σ2Y j + σ
2
Xjβ
2
0
+
p∑
j=1
(ej − β0j)[ejσ2Xjβ0 + jσ2Y j ]
(σ2Y j + σ
2
Xjβ
2
0)
2
.
The first term on the right hand side is distributed as N(0, V2) and V2 =
Θ(n‖γ‖22). The second term has variance O(p) and is thus ignorable com-
pared to the first term. Therefore, (1/
√
V2)ψ(β0)
d→ N(0, 1). Since p/n→ 0,
it is easy to show that V1/V2 → 1. By Slutsky’s lemma, (1/
√
V1)ψ(β0)
d→
N(0, 1).
Now we turn to Lemma B.2. It suffices to prove E[ψ′(β0)] = V2 and
Var(ψ′(β0)/V2)→ 0. Next we compute the first two moments of ψ′(β0). By
differentiating (3.5), we get
ψ′(β0) =
p∑
j=1
Aj +Bj
(σ2Y j + σ
2
Xjβ
2
0)
4
,
where
Aj = (Γˆ
2
jσ
2
Xj − γˆ2j σ2Y j − 2β0γˆjΓˆjσ2Xj)(σ2Y j + σ2Xjβ20)2,
Bj = −(Γˆj − β0γˆj)(γˆjσ2Y j + Γˆjσ2Xjβ0) · 2(σ2Y j + σ2Xjβ20) · 2σ2Xjβ0.
The expected values of these two terms are
E[Aj ] =
[
(Γ2j + σ
2
Y j)σ
2
Xj − (γ2j + σ2Xj)σ2Y j − 2β0γjΓjσ2Xj
]
(σ2Y j + σ
2
Xjβ
2
0)
2
= −(γ2j σ2Y j + Γ2jσ2Xj)(σ2Y j + σ2Xjβ20)2,
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E[Bj ] = −
[
(Γ2j + σ
2
Y j)σ
2
Xjβ0 − (γ2j + σ2Xj)σ2Y jβ0 + Γjγj(σ2Y j − σ2Xjβ20)
]·
· 2(σ2Y j + σ2Xjβ20) · 2σ2Xjβ0
= −[(Γ2jσ2Xj − γ2j σ2Y j)β0 + Γjγj(σ2Y j − σ2Xjβ20)] · 4(σ2Y j + σ2Xjβ20)σ2Xjβ0
= 0.
Therefore E[ψ′(β0)] = −V2.
For the variance of ψ′(β0), consider any β in a neighborhood N of β.
Our argument is based on the key observation that ψj(β) is a homogeneous
quadratic polynomial of (γ˜j , e˜j , ˜j) = (
√
nγj ,
√
nej ,
√
nj):
ψj(β) =
((β0 − β)γ˜j + e˜j − β˜j)[(nσ2Xjββ0 + nσ2Y j)γ˜j + (nσ2Xjβ)e˜j + (nσ2Y j)˜j ]
(nσ2Xjβ
2 + nσ2Y j)
2
.
Therefore its derivative, ψ′j(β), remains to be a homogeneous quadratic poly-
nomial of (γ˜j , e˜j , ˜j). This observation suggests that E[ψ′j(β0)] is a quadratic
function of γ˜j . Notice that the any term in ψ
′
j(β) that has odd degree of γ˜j
must have expectation equal to 0, because it must have odd degree in either
e˜j or ˜j . A simple calculation then yields E[ψ′j(β)]] = Θ(γ˜2j ), so for β ∈ N ,
E[ψ′(β)] = Θ(n‖γ‖22).
Similarly, the variance Var[ψ′j(β)
2] is also a quadratic polynomial of γ˜j (be-
cause the γ˜2j term in ψ
′
j(β) is non-random). Thus for β ∈ N ,
Var(ψ′(β)) = O(n‖γ‖22 + p).
Using the assumption p/(n2‖γ‖4)→ 0, it is then easy to see that
Var(ψ′(β0))
(
E[ψ′(β0)]
)2
.
This concludes the proof of Lemma B.2.
The above argument for ψ′(β0) can also be applied to ψ′′(β) for any β
in a neighborhood N of β0, so Var(ψ′′(β)) = O(n‖γ‖22 + p) = o(V 22 ). Since
ψ(β) is smooth in β, this proves the Lemma B.3.
B.3. Proof of Theorem 3.3. By Theorem 3.2, βˆ − β0 = Op(1/
√
n).
Thus
σ2Y j + σ
2
Xj βˆ
2 = (σ2Y j + σ
2
Xjβ
2
0)(1 + op(1/n)).
This implies that
Vˆ1 = (1 + op(1)) ·
p∑
j=1
(γˆ2j − σ2Xj)σ2Y j + (Γˆ2j − σ2Y j)σ2Xj + σ2Xjσ2Y j
(σ2Y j + σ
2
Xjβ
2
0)
2
.
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It is easy to show that the summation on the right hand side has mean V1.
Similar to the proof of Theorem 3.2, the variance of this term is O(p). Note
that V1 = Θ(n‖γ‖22+p) = Θ(p·(1+κ)), using the assumption in Theorem 3.2
that p → ∞ or κ → ∞, Vˆ1 = (1 + op(1))V1. Similarly, Vˆ2 = (1 + op(1))V2.
Equation (3.9) follows immediately from Slutsky’s lemma.
B.4. Proof of Theorem 4.1. To prove consistency of (βˆ, τˆ20 ), we need
to study the asymptotic behavior of the adjusted profile score. Let ψ1j(β, τ
2)
and ψ2j(β, τ
2) be the j-th term in the summation in (4.2) and (4.3), so
ψi(β, τ
2) =
∑p
j=1 ψij(β, τ
2), i = 1, 2. We first consider the expectation of
ψ1j and ψ2j :
E[ψ1j(β, τ2)]
=E
{
[(ej − βj) + (β0 − β)γj ][γj(σ2Xjββ0 + σ2Y j + τ2) + j(σ2Y j + τ2) + ejσ2Xjβ]
(σ2Xjβ
2 + σ2Y j + τ
2)2
}
=
(τ2 + σ2Y j + σ
2
Xjββ0)(β0 − β)γ2j + σ2Xjβ(τ20 − τ2)
(τ2 + σ2Y j + σ
2
Xjβ
2)2
,
and
E[ψ2j(β, τ2)] = E
{
σ2Xj
[(ej − βj) + (β0 − β)γj ]2 − (τ2 + σ2Y j + σ2Xjβ2)
(τ2 + σ2Y j + σ
2
Xjβ
2)2
}
=
σ2Xj(β0 − β)2γ2j + σ2Xj(τ20 − τ2)
(τ2 + σ2Y j + σ
2
Xjβ
2)2
.
(B.2)
Now consider the following contrast of the two estimating equations:
ψ˜(β, τ2) = ψ1(β, τ
2)− βψ2(β, τ2).
It is straightforward to verify that
E[ψ˜(β, τ2)] =
p∑
j=1
(β0 − β)γ2j (τ2 + σ2Y j + σ2Xjββ0 − βσ2Xj(β0 − β))
(τ2 + σ2Y j + σ
2
Xjβ
2)2
=
p∑
j=1
(β0 − β)γ2j
τ2 + σ2Y j + σ
2
Xjβ
2
.
In other words, E[ψ˜(β, τ2)] = 0 if and only if β = β0.
Next we bound the variance of ψ˜(β, τ2) over B. Because of Assumptions 3
and 4, Var(j) = Θ(1/n) and Var(ej) = Θ(1/n+ 1/p). Using the inequality
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Var(X + Y ) ≤ 2[Var(X) + Var(Y )] repeatedly, we have
Var(ψ˜(β, τ2)) = O
(
Var(ψ1(β, τ
2))
)
+O
(
Var(ψ2(β, τ
2))
)
,
and, after some algebra,
Var(ψ1(β, τ
2)) = O((n+ p)‖γ‖22 + p) = o(n2), and
Var(ψ2(β, τ
2)) = O((n+ p)‖γ‖22 + p) = o(n2).
To summarize, we have shown that
ψ˜(β, τ2) = (β0 − β) ·Θ(n) + op(n),(B.3)
ψ2(β, τ
2) = (β0 − β)2Θ(n) + (pτ20 − pτ)Θ(n) + op(n).(B.4)
Consider a box B′ = [−C1, C1]× [0, C2] that contains B. Using (B.3) and
(B.4), if C1 and C2/C1 are sufficiently large, all the following events have
probabilities going to 1:
sup
|pτ2|≤C2
ψ˜(C1, τ
2) ≤ 0, inf
|pτ2|≤C2
ψ˜(−C1, τ2) ≥ 0,
sup
|β|≤C1
ψ2(β,C2/p) ≤ 0, inf|β|≤C1 ψ2(β, 0) ≥ 0.
If all the events are true, by continuity of ψ˜ and ψ2 and the Poincare´-Miranda
theorem, there exists (βˆ, pτˆ2) ∈ B′ such that
ψ˜(βˆ, τˆ2) = ψ2(βˆ, τˆ
2) = 0.
Using (B.3) and (B.4), it is then straightforward to show βˆ
p→ β0 and (pτˆ2−
pτ20 )
p→ 0. As a consequence, (βˆ, pτˆ2) ∈ B with probability going to 1, thus
concluding our proof.
B.5. Proof of Theorem 4.2. We begin with proving V˜1 and V˜2 are
the corresponding moments of ψ(β0, τ
2
0 ) and ∇ψ(β0, τ20 ).
Lemma B.4. Var(ψ(β0, τ
2
0 )) = V˜1, E[∇ψ(β0, τ20 )] = V˜2.
Proof of Lemma B.4. In Section 4.2 we have already shown that E[ψ(β0, τ20 )] =
0. The variance of ψ1(β0, τ
2
0 ) and the expectation of (∂/∂β)ψ1(β0, τ
2
0 ) can
be obtained from the proof of Theorem 3.2 by replacing σ2Y j with σ
2
Y j + τ
2
0 .
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Next we compute the other moments. Let ψ1j(β, τ
2) and ψ2j(β, τ
2) be the
j-th summand in (4.2) and (4.3), so ψi(β, τ
2) =
∑p
j=1 ψij(β, τ
2) for i = 1, 2.
Because Γˆj − β0γˆj ∼ N(0, β20σ2Xj + Σ2Y j + τ20 ), it is easy to see that
Var(ψ2j(β0, τ
2
0 )) =
2(σ2Xj)
2
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
The covariance of ψ1j and ψ2j is given by
Cov(ψ1j(β0, τ
2
0 ), ψ2j(β0, τ
2
0 ))
=E
[ (Γˆj − β0γˆj)(γˆj(τ20 + σ2Y j) + Γˆjσ2Xjβ0)σ2Xj [(Γˆj − β0γˆj)2 − (σ2Xjβ20 + σ2Y j + τ20 )]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=σ2XjE
[ (Γˆj − β0γˆj)3(γˆj(σ2Y j + τ20 ) + Γˆjσ2Xjβ0)
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=σ2XjE
[ (ej − β0j)3[γj(σ2Xjβ20 + σ2Y j + τ20 ) + j(σ2Y j + τ20 ) + ejσ2Xjβ0]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=σ2XjE
[ (ej − β0j)3[j(σ2Y j + τ20 ) + ejσ2Xjβ0]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=σ2XjE
[e4jσ2Xjβ0 + e2j2j [−3β0(σ2Y j + τ20 ) + 3β20σ2Xjβ0]− 4jβ30(σ2Y j + τ20 )
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=0.
Thus Var(ψ(β0, τ
2
0 )) = V˜1. Next we consider the expectation of ∇ψ(β0, τ20 ):
E
[ ∂
∂τ2
ψ1j(β
2
0 , τ
2
0 )
]
=E
[(Γˆj − β0γˆj)γˆj(σ2Xjβ20 + σ2Y j + τ20 )2
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
−
− E
[(Γˆj − β0γˆj)(γˆj(σ2Y j + τ20 ) + Γˆjσ2Xjβ0) · 2(σ2Xjβ20 + σ2Y j + τ20 )
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
]
=E
[(Γˆj − β0γˆj)[γˆj(σ2Xjβ20 − σ2Y j − τ20 )− 2Γˆjσ2Xjβ0]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
]
=E
[(ej − β0j)[j(σ2Xjβ20 − σ2Y j − τ20 )− 2ejσ2Xjβ0]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
]
=
−2(σ2Y j + τ20 )σ2Xjβ0 − β0σ2Xj(σ2Xjβ20 − σ2Y j − τ20 )
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
=
−σ2Xjβ0
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
.
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Furthermore,
∂
∂β
ψ2j(β0, τ0) = σ
2
Xj
Dj − Ej
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
4
where
Dj = [2(Γˆj − β0γˆj)(−γˆj)− 2σ2Xjβ0](τ20 + σ2Y j + σ2Xjβ20)2,
Ej = [(Γˆj − β0γˆj)2 − (τ20 + σ2Y j + σ2Xjβ20)] · 2(τ20 + σ2Y j + σ2Xjβ20)σ2Xj · 2β0.
It is not hard to see that both Dj and Ej have mean 0. Finally,
∂
∂τ20
ψ2j(β0, τ0)
=− σ
2
Xj
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
− 2σ
2
Xj [(Γˆj − β0γˆj)2 − (σ2Xjβ20 + σ2Y j + τ20 )]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
It is easy to see that
E
[ ∂
∂τ2
ψ2j(β0, τ0)
]
= − σ
2
Xj
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
.
In summary, we have proved that E[∇ψ(β0, τ20 )] = −V˜2.
It is useful to write down the order of V˜1 and V˜2:
V˜1 =
(
Θ(n) 0
0 Θ(n)
)
, V˜2 =
(
Θ(n) Θ(n2)
0 Θ(n2)
)
.(B.5)
Similar to the proof of Theorem 3.2, consider the Taylor expansion (let
θ = (β, τ2))
(B.6)
0 = ψ(θˆ) = ψ(θ0) +∇ψ(θ0)(θˆ − θ0) + 1
2
(
(θˆ − θ0)T∂2ψ1(θ˜)(θˆ − θ0)
(θˆ − θ0)T∂2ψ2(θ˜)(θˆ − θ0).
)
By the consistency of (βˆ, pτˆ2) and three Lemmas listed after this paragraph,
the third term on the right hand side is negligible compared to the second
term. The central limit theorem (4.4) can then be proven by the same ar-
guments (normalizing by V˜1 and V˜2 and using Slutsky’s lemma) as in the
beginning of the proof of Theorem 3.2.
Lemma B.5. (V˜1)
−1/2ψ(β0, τ20 )
d→ N(0, I2).
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Lemma B.6. (V˜2)
−1∇ψ(β0, τ20 )
p→ −I2.
Lemma B.7. Denote ∂2ψi(β, τ
2) to be all the second-order partial deriva-
tives of ψi(β, τ
2), i = 1, 2. For a neighborhood N of (β0, pτ20 ) and l = 0, 1, 2,
sup
(β,τ2)∈N
∣∣∣ ∂2
∂β2−l(∂τ2)l
ψ1(β, τ
2)
∣∣∣ = Op(nl+1), and
sup
(β,τ2)∈N
∣∣∣ ∂2
∂β2−l(∂τ2)l
ψ2(β, τ
2)
∣∣∣ = Op(nl+1).
Next we prove Lemmas B.5 to B.7. Let ψj(β, τ
2) = (ψ1j(β, τ
2), ψ2j(β, τ
2))
for j ∈ [p]. Since ψj , j ∈ [p] are mutually independent and p→∞, it suffices
to verify the following Lyapunov condition [? ]
p∑
j=1
E
[‖V˜ −1/21 ψj(β0, τ20 )‖3]→ 0
to prove Lemma B.5. Because V˜1 is diagonal, it suffices to verify this for
each coordinate of ψj . Similar to the proof of Lemma B.1, we can show that
(B.7)
p∑
j=1
E[|ψ1j(β0, τ20 )|3] = O(p+
√
n‖γ‖1 + n‖γ‖22 + n3/2‖γ‖33).
Therefore, using ‖γ‖3/‖γ‖2 → 0, we obtain∑p
j=1 E[|ψ1j(β0)|3]
(V˜1)
3/2
11
= O
(p+√n‖γ‖1 + n‖γ‖22 + n3/2‖γ‖33
n3/2
)
→ 0.
For ψ2, since the third moment of a χ
2
1 distribution exists,
E[|ψ2j(β0, τ20 )|3] = O
( σ6Xj
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
)
= O(1).
Thus ∑p
j=1 E[|ψ2j(β0)|3]
(V˜1)
3/2
22
= O
( p
n3/2
)
= O(n−1/2)→ 0.
This completes our proof of Lemma B.5.
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For Lemmas B.6 and B.7, it remains to bound the variance of ∇ψ and
∂2ψ. Notice that, similar to the proof of Lemmas B.2 and B.3, ψ1j(β, τ
2) is a
homogeneous quadratic polynomial of (γ˜j , e˜j , ˜j) = (γj/
√
n, ej/
√
n, j/
√
n):
ψ1j(β) =
[
(β0 − β)γ˜j + e˜j − β˜j
]
[nσ2Xjβ
2 + n(σ2Y j + τ
2)]2
·
· [(nσ2Xjββ0 + n(σ2Y j + τ2))γ˜j + (nσ2Xjβ)e˜j + (nσ2Y j)˜j].
Therefore, its derivatives with respect to β and τ2 remain to be homogeneous
quadratic polynomials. As in the proof of Lemma B.2, this suggests that,
for (β, pτ2) ∈ B, (recall that ‖γ‖4 ≤ ‖γ‖3  ‖γ‖2)
Var
( ∂
∂β
ψ1(β, τ
2)
)
≤ E
[( ∂
∂β
ψ1(β, τ
2)
)2]
= O
(
n2‖γ‖44 + n‖γ‖22 + p
)
= o((V˜2)
2
11).
(B.8)
Therefore (V˜2)
−1
11 (∂/∂β)ψ1(β0, τ
2
0 )
p→ −1, where (V )−1ij means the reciprocal
of the (i, j)-th entry of V . Similarly,
(B.9) Var
(
(∂/∂τ2)ψ1(β, τ
2)
)
= O
(
n[n2‖γ‖44 + n‖γ‖22 + p]
)
= o((V˜2)
2
12).
The extra n comes from differentiating with respect to τ2 = O(1/p) =
O(1/n). So ((V˜2)12)
−1(∂/∂τ2)ψ1(β, τ2)
p→ −1.
For ψ2, we have
ψ2j(β, τ
2) =
σ2Xj
σ2Xjβ
2
0 + σ
2
Y j + τ
2
0
[[
(β0 − β)γ˜j + e˜j − β˜j
]2
nσ2Xjβ
2 + n(σ2Y j + τ
2)
− 1
]
.
Using the same argument,
Var
(
(∂/∂β)ψ2(β, τ
2)
)
= O
(
n2‖γ‖44 + n‖γ‖22 + p
)
= o((V˜2)11),(B.10)
Var
(
(∂/∂τ2)ψ2(β, τ
2)
)
≤ O(n[n2‖γ‖44 + n‖γ‖22 + p]) = o((V˜2)222).(B.11)
Therefore ((V˜2)22)
−1(∂/∂τ2)ψ2(β, τ2)
p→ −1. We cannot claim the same
conclusion for (∂/∂τ2)ψ2(β, τ
2) because (V˜2)21 = 0. Nevertheless, the above
results are already enough to verify Lemma B.6, because
(V˜2)
−1∇ψ(β0, τ20 ) =
(
(V˜2)
−1
11 −(V˜2)−111 (V˜2)−122 (V˜2)12
0 (V˜2)
−1
22
)( ∂
∂βψ1
∂
∂τ2ψ1
∂
∂βψ2
∂
∂τ2ψ2
)
=
(
(V˜2)
−1
11
∂
∂βψ1 − L ∂∂βψ2 (V˜2)−111 ∂∂τ2ψ1 − L ∂∂τ2ψ2
(V˜2)
−1
22
∂
∂βψ2 (V˜2)
−1
22
∂
∂τ2ψ2
)
,
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where L = (V˜2)
−1
11 (V˜2)
−1
22 (V˜2)12 = Θ(n
−1). Using equations (B.8) to (B.11),
it is straightforward to verify that the right hand side converges to I2 in
probability.
Finally, Lemma B.7 can be proven similarly to Lemma B.3 using the rate
of the variances established above as they also extend to the second-order
derivative of ψ2.
B.6. Proof of Theorem 5.1. It is easy to show E[ψ(ρ)2 (β0, τ20 )] = 0 by
using tj(β0, τ
2
0 ) ∼ N(0, 1). For ψ(ρ)1 , since
(B.12) uj(β, τ
2) = − ∂
∂β
tj(β, τ
2) =
Γˆjσ
2
Xjβ + γˆj(σ
2
Y j + τ
2)
(σ2Xjβ
2 + σ2Y j + τ
2)3/2
,
it is straightforward to verify that
E
[
tj(β0, τ
2
0 ) · uj(β0, τ20 )
]
= E
[
(Γˆj − β0γˆj)
[
Γˆjσ
2
Xjβ0 + γˆj(σ
2
Y j + τ
2
0 )
]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
]
= 0.
Since tj(β0, τ
2
0 ) and uj(β0, τ
2
0 ) are linear transformations of jointly normal
random variables, this implies that tj(β0, τ
2
0 ) ⊥ uj(β0, τ20 ). Therefore
E[ψ(ρ)1j (β0, τ
2
0 )] ∝ E[ρ′(tj(β0, τ20 )) · uj(β0, τ20 )] = 0.
By Lemma B.8 below, E[∇ψ(ρ)] = −V˜ (ρ)2 has full rank because δ, c3 > 0.
B.7. Proof of Theorem 5.2. Similar to the proof of Theorem 4.2, we
first show V˜
(ρ)
1 is the variance of ψ
(ρ) and V˜
(ρ)
2 is the expectation of −∇ψ(ρ)
at the true parameter (β, τ2) = (β0, τ
2
0 ).
Lemma B.8. Var
(
ψ(ρ)(β0, τ
2
0 )
)
= V˜
(ρ)
1 , E
[∇ψ(ρ)(β0, τ20 )] = −V˜ (ρ)2 .
Proof of Lemma B.8. Let ψ
(ρ)
1j and ψ
(ρ)
2j be the j-th summand in (5.2)
and (5.3). We will use the shorthand notation tj0 = tj(β0, τ
2
0 ) and uj0 =
uj(β0, τ
2
0 ).
Because ρ′ is an odd function and tj0 ∼ N(0, 1), we have E[ρ′(tj0)] = 0.
Using tj0 ⊥ uj0 (see Appendix B.6), we obtain
Var
(
ψ
(ρ)
1j (β0, τ
2
0 )
)
= Var
(
ρ′(tj0
)
uj0) = c1E
[
u2j0
]
.
If we let ρ(r) = r2/2 be the l2-loss (so c1 = 1), we recover the APS so
E[uj0] = (V˜1)11. Thus Var
(
ψ
(ρ)
1j (β0, τ
2
0 )
)
= c1(V˜1)11.
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The covariance of ψ
(ρ)
1j and ψ
(ρ)
2j is
Cov
(
ψ
(ρ)
1j (β0, τ
2
0 ), ψ
(ρ)
2j (β0, τ
2
0 )
)
∝E
{
ρ′(tj0)uj0 ·
[
tj0ρ
′(tj0)− δ
]}
=E[uj0] · E
{
ρ′(tj0) ·
[
tj0ρ
′(tj0)− δ
]}
=0.
The last expectation is 0 because ρ′ is an odd function.
The variance of ψ
(ρ)
2j is
Var
(
ψ
(ρ)
2j (β0, τ
2
0 )
)
=
(σ2Xj)
2
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
Var
(
tj0ρ
′(tj0)
)
= c2(V˜1)22.
Next we turn to the derivatives of ψ(ρ). First, by the chain rule,
∂
∂β
ψ
(ρ)
1j (β, τ
2) = −ρ′′(tj(β, τ2))uj(β, τ2)2 + ρ′(tj(β, τ2)) ∂
∂β
uj(β, τ
2).
The expectation of the first term at (β0, τ
2
0 ) is
E[−ρ′′(tj0)u2j0] = −E[ρ′′(tj0)]E[u2j0] = δ(V˜2)11,
where we have used the identity E[ρ′′(R)] = E[Rρ′(R)] forR ∼ N(0, 1), which
can be proved by integration by parts and the fact that φ′(x) = −xφ(x).
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The second term requires more calculations:
E
[
[ρ′(tj0) ·
( ∂
∂β
uj(β, τ
2)
)∣∣∣
(β,τ2)=(β0,τ20 )
]
=E
[
ρ′(tj0) · ∂
∂β
(
γˆj(τ
2
0 + σ
2
j2) + Γˆjσ
2
j1β
)∣∣∣
β=β0
· 1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
]
+ E
[
ρ′(tj0) · (γˆj(τ20 + σ2j2) + Γˆjσ2j1β0) ·
∂
∂β
( 1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
)∣∣∣
β=β0
]
=E
[
ρ′(tj0) · ∂
∂β
(
γˆj(τ
2
0 + σ
2
j2) + Γˆjσ
2
j1β
)∣∣∣
β=β0
· 1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
]
=E
[
ρ′(tj0) · Γˆjσ2j1 ·
1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
]
=
σ2Xj
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
E[ρ′(tj0)(Γj + ej)]
=
σ2Xj
√
σ2Y j + τ
2
0
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
E
[
ρ′(tj0) · ej√
τ20 + σ
2
j2
]
.
The second equality above is because tj0 ⊥ uj0 and E[ρ′(tj0)] = 0. Notice
that tj0 and ej
/√
τ20 + σ
2
j2 are marginally distributed as the standard normal
and
Cov
(
tj0,
ej√
σ2Y j + τ
2
0
)
=
( σ2Y j + τ20
σ2Xjβ
2
0 + σ
2
Y j + τ
2
0
)1/2
.
It is not difficult to verify that ifR1, R2 are N(0, 1) marginally and Cov(R1, R2) =
λ, then E[ρ′(R1)R2] = λδ. Thus
(B.13) E
[
[ρ′(tj0) · ∂
∂β
uj0
]
= δ · σ
2
Xj(σ
2
Y j + τ
2
0 )
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
= δ[(V˜1)11 − (V˜2)11].
To summarize,
E
[ ∂
∂β
ψ
(ρ)
1j (β0, τ
2
0 )
]
= −δ(V˜1)11 + δ[(V˜1)11 − (V˜2)11] = −δ(V˜2)11.
The other first-order derivative of ψ
(ρ)
1j is
E
[
∂
∂τ2
ψ
(ρ)
1j (β0, τ
2
0 )
]
= E
[
ρ′′(tj0)
( ∂
∂τ2
tj0
)
uj0 + ρ
′(tj0)
( ∂
∂τ2
uj0
)]
.
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Using
(B.14)
∂
∂τ2
tj(β, τ
2) = − tj(β, τ
2)
2(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
and the independent of tj0, it is straightforward to show the first term has
mean 0. For the second term,
E
[
ρ′(tj0)
( ∂
∂τ2
uj0
)]
= E
[
ρ′(tj0) · γˆj 1
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
]
Similar to the derivation of (B.13), one can show that
E
[
ρ′(tj0)
( ∂
∂τ2
uj0
)]
=
−δβ0σ2Xj
σ2Xjβ
2
0 + σ
2
Y j + τ
2
0
= −δ · (V˜2)12.
Finally we consider the derivatives of ψ
(ρ)
2j . Using (B.14), we have
E
[
∂
∂τ2
ψ
(ρ)
2j (β0, τ
2
0 )
]
= E
[
σ2Xj
−tj0ρ′(tj0)/2− t2j0ρ′′(tj0)/2− (tj0ρ′(tj0)− δ)
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
]
= −δ + c3
2
· σ
2
Xj
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
Hence
E
[
∂
∂τ2
ψ
(ρ)
2 (β0, τ
2
0 )
]
= −[(δ + c3)/2](V˜2)22.
The last partial derivative is (∂/∂β)ψ
(ρ)
2 . Its expectation at (β0, τ
2
0 ) is
E
[ ∂
∂β
ψ
(ρ)
2j (β0, τ
2
0 )
]
=E
[ ∂
∂β
[
tj0ρ
′(tj0)− δ
]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
]
+ E
[
∂
∂β
[ 1
(σ2Xjβ
2 + σ2Y j + τ
2
0 )
2
]∣∣∣
β=β0
·
[
tj0ρ
′(tj0)− δ
]]
=E
[ ∂
∂β
[
tj0ρ
′(tj0)− δ
]
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
]
=E
[−uj0ρ′(tj0)− tj0ρ′′(tj0)uj0
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
2
]
=0.
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The last equation is due to the independence of tj0 and uj0 and the fact
that ρ′(r) and rρ′′(r) are odd functions of r.
To prove asymptotic normality of the RAPS estimator, we just need to
verify Lemmas B.5 to B.7 with ψ replaced by ψ(ρ) and V˜1, V˜2 replaced by
V˜
(ρ)
1 , V˜
(ρ)
2 . This requires verifying the Lyapunov condition for the central
limit theorem in Lemma B.5 and bounding the derivatives of ψ(ρ) to prove
Lemmas B.6 and B.7.
It is useful to notice that the rates of V˜1 and V˜2 in (B.5) still apply to
V˜
(ρ)
1 and V˜
(ρ)
2 . First, using the boundedness of ρ
′, we have
p∑
j=1
E
[|ψ(ρ)1j (β0, τ20 )|3] = p∑
j=1
E[|ρ′(tj0)|3] · E[|uj0|3] = O
( p∑
j=1
E[|uj0|3]
)
.
We can rewrite (B.12) as
uj0 =
(γj
√
n)(σ2Xjβ0 + σ
2
Y j + τ
2
0 ) + (ej
√
n)(σ2Xjβ0) + (j
√
n)(σ2Y j + τ
2
0 )
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3/2
√
n
.
So uj0 is a linear combination of γj
√
n, ej
√
n, j
√
n. Using the same argu-
ment in Appendix B.5, for any positive integer k,
(B.15) E[|uj0|k] = O
( k∑
l=0
(√
n|γj |+ 1
)l)
= O
( k∑
l=0
(
√
n)l|γj |l
)
.
From this it is easy to verify equation (B.7) still holds for ψ
(ρ)
1j (β0, τ
2
0 ), j =
1, 2, . . . , which implies that∑p
j=1 E
[∣∣ψ(ρ)1j (β0, τ20 )∣∣3]
(V˜
(ρ)
1 )
3/2
11
→ 0.
Furthermore,
p∑
j=1
E
[|ψ(ρ)2j (β0, τ20 )|3] = p∑
j=1
(σ2Xj)
3
(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
3
· c5
where c5 = E[|Rρ′(R)− δ|3] for R ∼ N(0, 1). Thus
p∑
j=1
E
[|ψ(ρ)2j (β0, τ20 )|3] = O(p) (V˜ (ρ)1 )3/222 .
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To summarize, we have verified the Lyapunov condition for ψ
(ρ)
j . Conse-
quently, the central limit theorem (V˜
(ρ)
1 )
−1/2ψ(ρ)(β0, τ20 )
d→ N(0, I2) holds.
Next we restablish the variance bounds, namely equations (B.8) to (B.11),
for ψ(ρ). Similar to Appendix B.5, we extend (B.15), the bound on the
moments of uj , to the derivatives of uj : for (β, pτ
2) ∈ B,
(B.16) E
[∣∣∣ ∂l1+l2
∂βl1(∂τ2)l2
uj(β, τ
2)
∣∣∣k] = O(nl2 k∑
l=0
(
√
n)l|γj |l
)
.
Similarly,
(B.17) E
[∣∣tj(β, τ2)∣∣k] = O( k∑
l=0
(
√
n)l|γj |l
)
.
Consider a partial derivative of ψ
(ρ)
1j :
∂l1+l2
∂βl1(∂τ2)l2
ψ
(ρ)
1j (β, τ
2) =
∂l1+l2
∂βl1(∂τ2)l2
ρ′(tj(β, τ2))uj(β, τ2).
By equations (B.12) and (B.14), It is a polynomial of derivatives (up to
(l1 + l2 + 1)-th order) of ρ(tj(β, τ
2)), tj(β, τ
2), uj(β, τ
2), and derivatives of
uj(β, τ
2), for which we all have moment bounds. We will use the shorthand
notation tj = tj(β, τ
2) and uj = uj(β, τ
2) below. In particular,
∂
∂β
ψ
(ρ)
1j (β, τ
2) = −ρ′′(tj)u2j + ρ′(tj)
∂
∂β
uj .
Using the boundedness of ρ′ and ρ′′ and equation (B.16), we have
Var
( ∂
∂β
ψ
(ρ)
1
)
≤ E
[( ∂
∂β
ψ
(ρ)
1
)2]
= O
( p∑
j=1
u4j +
( ∂
∂β
uj
)2)
= O
( 4∑
l=0
(
√
n)l‖γ‖ll
)
= o
(
(V˜
(ρ)
2 )
2
11
)
Similarly,
∂
∂τ2
ψ
(ρ)
1j = −ρ′′
(
tj
) tjuj
2(σ2Xjβ
2
0 + σ
2
Y j + τ
2
0 )
+ ρ′
(
tj
) ∂
∂τ2
uj .
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Using the Cauchy-Schwarz inequality, we obtain
Var
( ∂
∂τ2
ψ
(ρ)
1
)
≤ E
[( ∂
∂τ2
ψ
(ρ)
1
)2]
= O
(
E
[ p∑
j=1
t4j + u
4
j
(1/n)2
+
( ∂
∂τ2
uj
)2])
= O
(
n2
4∑
l=0
(
√
n)l‖γ‖ll + n
2∑
l=0
(
√
n)l‖γ‖ll
)
= o
(
(V˜
(ρ)
2 )
2
12
)
.
Next we consider the derivatives of ψ
(ρ)
2 :
∂
∂β
ψ
(ρ)
2j =
σ2Xj
σ2Xjβ
2 + σ2Y j + τ
2
·
[
− ujρ′
(
tj
)− tjρ′′(tj)uj]−
− σ
4
Xjβ
(σ2Xjβ
2 + σ2Y j + τ
2)2
· [tjρ′(tj)− δ],
thus, again using the Cauchy-Schwarz inequality,
E
[( ∂
∂β
ψ
(ρ)
2
)2]
= O
(
E
[ p∑
j=1
u2j + (t
4
j + u
4
j ) + t
2
j
])
= O
( 4∑
l=0
(
√
n)l‖γ‖ll
)
= o
(
(V˜
(ρ)
2 )22
)
.
Finally,
∂
∂τ2
ψ
(ρ)
2j =
σ2Xj
σ2Xjβ
2 + σ2Y j + τ
2
·
[
− tj
2(σ2Xjβ
2 + σ2Y j + τ
2)
(ρ′(tj)− tjρ′′(tj))
]
−
− σ
2
Xj
(σ2Xjβ
2 + σ2Y j + τ
2)2
· [tjρ′(tj)− δ].
Thus
E
[( ∂
∂τ2
ψ
(ρ)
2
)2]
= O
(
1
1/n
E
[ p∑
j=1
t2j + t
4
j
])
= O
(
n
4∑
l=0
(
√
n)l‖γ‖ll
)
= o
(
(V˜
(ρ)
2 )
2
22
)
.
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In summary, we have re-established equations (B.8) to (B.11) for ψ(ρ).
Therefore Lemma B.6 still holds for ψ(ρ) with V˜2 replaced by V˜
(ρ)
2 .
Finally we prove Lemma B.7 for the RAPSψ(ρ). Notice that, for (β, pτ2) ∈
B, tj(β, τ2) = Op(
√
n|γj | + 1) and uj(β, τ2) = Op(
√
n|γj | + 1). These rates
also hold for the partial derivatives of tj and uj with respect to β. Therefore,
by the boundedness of ρ′, ρ′′ and ρ′′′,
∂2
∂β2
ψ
(ρ)
1j (β, τ
2) = ρ′′′(tj)u3j−3ρ′′(tj)uj
∂
∂β
uj+ρ
′(tj)
∂
∂β
uj = Op
(
(
√
n|γj |+1)3
)
.
Hence
∂2
∂β2
ψ
(ρ)
1 (β, τ
2) =
p∑
j=1
∂2
∂β2
ψ
(ρ)
1j (β, τ
2) = Op(p+
√
n‖γ‖1 +n‖γ‖22 +n3/2‖γ‖33).
Using the assumption that ‖γ‖33 = O(1/
√
p), it is easy to show that the right
hand side is Op(n) = Op
(
(V˜
(ρ)
2 )11
)
. Rates of the other partial derivatives
can be proved analogously and we omit further detail.
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